Publications

  1. Cleeland CS, Mayer M, Dreyer NA, Yim YM, Yu E, Su Z, Mun Y, Sloan JA, Kaufman PA. Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study. Breast. 2014 Sep 02.
    View PubMed
  2. Bingener J, Sloan JA, Novotny PJ, Pockaj BA, Nelson H. Perioperative Patient-Reported Outcomes Predict Serious Postoperative Complications: a Secondary Analysis of the COST Trial. J Gastrointest Surg. 2014 Aug 5. [Epub ahead of print]
    View PubMed
  3. Shanafelt TD, Raymond M, Horn L, Moynihan T, Collichio F, Chew H, Kosty MP, Satele D, Sloan J, Gradishar WJ. Oncology Fellows' Career Plans, Expectations, and Well-Being: Do Fellows Know What They Are Getting Into? J Clin Oncol. 2014 Jul 21.
    View PubMed
  4. Barton DL, Thanarajasingam G, Sloan JA, Diekmann B, Fuloria J, Kottschade LA, Lyss AP, Jaslowski AJ, Mazurczak MA, Blair SC, Terstriep S, Loprinzi CL. Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance). Cancer. 2014 Jul 09.
    View PubMed
  5. Shahi V, Lapid MI, Kung S, Atherton PJ, Sloan JA, Clark MM, Rummans TA. Do age and quality of life of patients with cancer influence quality of life of the caregiver? J Geriatr Oncol. 2014 Jul; 5(3):331-6. Epub 2014 Apr 14.
    View PubMed
  6. Hubbard JM, Grothey AF, McWilliams RR, Buckner JC, Sloan JA. Physician Perspective on Incorporation of Oncology Patient Quality-of-Life, Fatigue, and Pain Assessment Into Clinical Practice. J Oncol Pract. 2014 Jul; 10(4):248-53. Epub 2014 Mar 25.
    View PubMed
  7. Sloan JA, Sargent DJ, Novotny PJ, Decker PA, Marks RS, Nelson H. Calibration of Quality-Adjusted Life Years for Oncology Clinical Trials. J Pain Symptom Manage. 2014 Jun; 47(6):1091-1099.e3. Epub 2013 Nov 15.
    View PubMed
  8. Lesperance M, Shannon R, Pumphrey PK, Dunbar E, Genther R, Coleman CL, Tabano M, Maurer J, Vazquez A, Capp E, McMillan J, Wilkerson K, Robbins G, Phillips DG, Howick P, Solaun C, Sloan J, Colon-Otero G. Training mid-level providers on palliative care: bringing advanced directives and symptom assessment and management to community oncology practices. Am J Hosp Palliat Care. 2014 May; 31(3):237-43. Epub 2013 Apr 23.
    View PubMed
  9. Shanafelt TD, Raymond M, Kosty M, Satele D, Horn L, Pippen J, Chu Q, Chew H, Clark WB, Hanley AE, Sloan J, Gradishar WJ. Satisfaction with work-life balance and the career and retirement plans of US oncologists. J Clin Oncol. 2014 Apr 10; 32(11):1127-35. Epub 2014 Mar 10.
    View PubMed
  10. West CP, Dyrbye LN, Rabatin JT, Call TG, Davidson JH, Multari A, Romanski SA, Hellyer JM, Sloan JA, Shanafelt TD. Intervention to promote physician well-being, job satisfaction, and professionalism: a randomized clinical trial. JAMA Intern Med. 2014 Apr; 174(4):527-33.
    View PubMed
  11. Shanafelt TD, Gradishar WJ, Kosty M, Satele D, Chew H, Horn L, Clark B, Hanley AE, Chu Q, Pippen J, Sloan J, Raymond M. Burnout and career satisfaction among US oncologists. J Clin Oncol. 2014 Mar 1; 32(7):678-86. Epub 2014 Jan 27.
    View PubMed
  12. Dyrbye LN, West CP, Satele D, Boone S, Tan L, Sloan J, Shanafelt TD. Burnout among U.S. medical students, residents, and early career physicians relative to the general U.S. population. Acad Med. 2014 Mar; 89(3):443-51.
    View PubMed
  13. Clark MM, Atherton PJ, Lapid MI, Rausch SM, Frost MH, Cheville AL, Hanson JM, Garces YI, Brown PD, Sloan JA, Richardson JW, Piderman KM, Rummans TA. Caregivers of patients with cancer fatigue: a high level of symptom burden. Am J Hosp Palliat Care. 2014 Mar; 31(2):121-5. Epub 2013 Feb 21.
    View PubMed
  14. Piderman KM, Johnson ME, Frost MH, Atherton PJ, Satele DV, Clark MM, Lapid MI, Sloan JA, Rummans TA. Spiritual quality of life in advanced cancer patients receiving radiation therapy. Psychooncology. 2014 Feb; 23(2):216-21. Epub 2013 Sep 9
    View PubMed
  15. Shanafelt TD, Kaups KL, Nelson H, Satele DV, Sloan JA, Oreskovich MR, Dyrbye LN. An interactive individualized intervention to promote behavioral change to increase personal well-being in US surgeons. Ann Surg. 2014 Jan; 259(1):82-8.
    View PubMed
  16. Dyrbye LN, Sotile W, Boone S, West CP, Tan L, Satele D, Sloan J, Oreskovich M, Shanafelt T. A survey of U.S. physicians and their partners regarding the impact of work-home conflict. J Gen Intern Med. 2014 Jan; 29(1):155-61. Epub 2013 Sep 17.
    View PubMed
  17. Dyrbye LN, Sotile W, Boone S, West CP, Tan L, Satele D, Sloan J, Oreskovich M, Shanafelt T. A survey of us physicians and their partners regarding the impact of work-home conflict. J Gen Intern Med. 2014 Jan; 29(1):155-61.
  18. Eton DT, Beebe TJ, Hagen PT, Halyard MY, Montori VM, Naessens JM, Sloan JA, Thompson CA, Wood DL. Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic. Patient Relat Outcome Meas. 2014; 5:7-15. Epub 2014 Feb 10.
    View PubMed
  19. Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, Brito JP, Boehmer K, Hasan R, Firwana B, Erwin P, Eton D, Sloan J, Montori V, Asi N, Dabrh AM, Murad MH. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014; 14:89. Epub 2014 Feb 26.
    View PubMed
  20. Gowan ME, Kirk RC, Sloan JA. Building resiliency: a cross-sectional study examining relationships among health-related quality of life, well-being, and disaster preparedness. Health Qual Life Outcomes. 2014; 12:85. Epub 2014 Jun 09.
    View PubMed
  21. West CP, Dyrbye LN, Rabatin JT, Call TG, Davidson JH, Multari A, Romanski SA, Henriksen Hellyer JM, Sloan JA, Shanafelt TD. Intervention to promote physicianwell-being, job satisfaction, and professionalism a randomized clinical trial. JAMA Internal Medicine. 2014; 174(4):527-33.
  22. Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, Weiss M, Mendoza TR, Lee JW, Fisch MJ. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013 Dec 15; 119(24):4333-40. Epub 2013 Sep 24.
    View PubMed
  23. Burnette BL, Dispenzieri A, Kumar S, Harris AM, Sloan JA, Tilburt JC, Kyle RA, Rajkumar SV. Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies. Cancer. 2013 Dec 15; 119(24):4308-15. Epub 2013 Sep 19.
    View PubMed
  24. Chock MM, Lapid MI, Atherton PJ, Kung S, Sloan JA, Richardson JW, Clark MM, Rummans TA. Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer. Int Psychogeriatr. 2013 Dec; 25(12):2077-86. Epub 2013 Sep 04.
    View PubMed
  25. Dyrbye LN, Varkey P, Boone SL, Satele DV, Sloan JA, Shanafelt TD. Physician satisfaction and burnout at different career stages. Mayo Clin Proc. 2013 Dec; 88(12):1358-67.
    View PubMed
  26. Ridgeway JL, Beebe TJ, Chute CG, Eton DT, Hart LA, Frost MH, Jensen D, Montori VM, Smith JG, Smith SA, Tan AD, Yost KJ, Ziegenfuss JY, Sloan JA. A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient care. PLoS Med. 2013 Nov; 10(11):e1001548. Epub 2013 Nov 12.
    View PubMed
  27. Lapid MI, Atherton PJ, Kung S, Cheville AL, McNiven M, Sloan JA, Clark MM, Rummans TA. Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer? Support Care Cancer. 2013 Sep; 21(9):2485-90. Epub 2013 Apr 23.
    View PubMed
  28. Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013 Aug 21; 105(16):1230-8. Epub 2013 Jul 13.
    View PubMed
  29. Brundage M, Blazeby J, Revicki D, Bass B, de Vet H, Duffy H, Efficace F, King M, Lam CLK, Moher D, Scott J, Sloan J, Snyder C, Yount S, Calvert M. Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards. Qual Life Res. 2013 Aug; 22(6):1161-75.
  30. Bingener J, Ghahfarokhi LS, Skaran P, Sloan J. Responsiveness of quality of life instruments for the comparison of minimally invasive cholecystectomy procedures. Surg Endosc. 2013 Jul; 27(7):2446-53. Epub 2013 Jan 26.
    View PubMed
  31. Frost MH, Novotny PJ, Johnson ME, Clark MM, Sloan JA, Yang P. Spiritual well-being in lung cancer survivors. Support Care Cancer. 2013 Jul; 21(7):1939-46. Epub 2013 Feb 19.
    View PubMed
  32. Atherton PJ, Smith T, Singh JA, Huntington J, Diekmann BB, Huschka M, Sloan JA. The relation between cancer patient treatment decision-making roles and quality of life. Cancer. 2013 Jun 15; 119(12):2342-9. Epub 2013 Apr 04.
    View PubMed
  33. Thompson CA, Hugo SE, Swetz KM, Novotny PJ, Sloan JA, Loprinzi CL, Moynihan TJ, Shanafelt TD. End-of-life care in a population-based cohort of cancer patients: clinical trial participation versus standard of care. BMJ Support Palliat Care. 2013 Jun; 3(2):181-7. Epub 2013 Mar 09.
    View PubMed
  34. Williams PD, Graham KM, Storlie DL, Pedace TM, Haeflinger KV, Williams DD, Otte D, Sloan JA, Williams AR. Therapy-related symptom checklist use during treatments at a cancer center. Cancer Nurs. 2013 May-Jun; 36(3):245-54.
    View PubMed
  35. Barton DL, Burger K, Novotny PJ, Fitch TR, Kohli S, Soori G, Wilwerding MB, Sloan JA, Kottschade LA, Rowland KM Jr, Dakhil SR, Nikcevich DA, Loprinzi CL. The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Support Care Cancer. 2013 Apr; 21(4):1185-92. Epub 2012 Nov 13.
    View PubMed
  36. Atherton PJ, Halyard MY, Sloan JA, Miller RC, Deming RL, Tai TH, Stien KJ, Martenson JA Jr. Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA. Support Care Cancer. 2013 Apr; 21(4):1193-9. Epub 2012 Nov 15.
    View PubMed
  37. Pardo-Crespo MR, Narla NP, Williams AR, Beebe TJ, Sloan J, Yawn BP, Wheeler PH, Juhn YJ. Comparison of individual-level versus area-level socioeconomic measures in assessing health outcomes of children in Olmsted County, Minnesota. J Epidemiol Community Health. 2013 Apr; 67(4):305-10. Epub 2013 Jan 15.
    View PubMed
  38. Callstrom MR, Dupuy DE, Solomon SB, Beres RA, Littrup PJ, Davis KW, Paz-Fumagalli R, Hoffman C, Atwell TD, Charboneau JW, Schmit GD, Goetz MP, Rubin J, Brown KJ, Novotny PJ, Sloan JA. Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer. 2013 Mar 1; 119(5):1033-41. Epub 2012 Oct 12.
    View PubMed
  39. Dyrbye LN, Satele D, Sloan J, Shanafelt TD. Utility of a brief screening tool to identify physicians in distress. J Gen Intern Med. 2013 Mar; 28(3):421-7. Epub 2012 Nov 06.
    View PubMed
  40. Shanafelt TD, Boone SL, Dyrbye LN, Oreskovich MR, Tan L, West CP, Satele DV, Sloan JA, Sotile WM. The medical marriage: a national survey of the spouses/partners of US physicians. Mayo Clin Proc. 2013 Mar; 88(3):216-25. Epub 2013 Feb 27.
    View PubMed
  41. Clark MM, Rummans TA, Atherton PJ, Cheville AL, Johnson ME, Frost MH, Miller JJ, Sloan JA, Graszer KM, Haas JG, Hanson JM, Garces YI, Piderman KM, Lapid MI, Netzel PJ, Richardson JW, Brown PD. Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer. Cancer. 2013 Feb 15; 119(4):880-7. Epub 2012 Aug 28.
    View PubMed
  42. Sood R, Sood A, Wolf SL, Linquist BM, Liu H, Sloan JA, Satele DV, Loprinzi CL, Barton DL. Paced breathing compared with usual breathing for hot flashes. Menopause. 2013 Feb; 20(2):179-84.
    View PubMed
  43. Stauder MC, Romero Y, Kabat B, Atherton PJ, Geno D, Deschamps C, Jatoi A, Sloan JA, Botros M, Jung KW, Arora AS, Miller RC, EABE Registry. Overall survival and self-reported fatigue in patients with esophageal cancer. Support Care Cancer. 2013 Feb; 21(2):511-9. Epub 2012 Jul 29
    View PubMed
  44. Cleeland CS, Sloan JA, Cella D, Chen C, Dueck AC, Janjan NA, Liepa AM, Mallick R, O'Mara A, Pearson JD, Torigoe Y, Wang XS, Williams LA, Woodruff JF, CPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force. Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force. Cancer. 2013 Jan 15; 119(2):411-20. Epub 2012 Aug 28.
    View PubMed
  45. Basch E, Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ, Sloan J, Wenzel K, Chauhan C, Eppard W, Frank ES, Lipscomb J, Raymond SA, Spencer M, Tunis S. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol. 2012 Dec 1; 30(34):4249-55. Epub 2012 Oct 15.
    View PubMed
  46. West CP, Dyrbye LN, Satele DV, Sloan JA, Shanafelt TD. Concurrent validity of single-item measures of emotional exhaustion and depersonalization in burnout assessment. J Gen Intern Med. 2012 Nov; 27(11):1445-52. Epub 2012 Feb 24.
    View PubMed
  47. Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A, Le-Lindqwister NA, Soori GS, Jaslowski AJ, Kelaghan J, Novotny PJ, Lachance DH, Loprinzi CL. Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1. Cancer. 2012 Oct 15; 118(20):5171-8. Epub 2012 Mar 13.
    View PubMed
  48. Shanafelt TD, Boone S, Tan L, Dyrbye LN, Sotile W, Satele D, West CP, Sloan J, Oreskovich MR. Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Arch Intern Med. 2012 Oct 8; 172(18):1377-85.
    View PubMed
  49. Dyrbye LN, Freischlag J, Kaups KL, Oreskovich MR, Satele DV, Hanks JB, Sloan JA, Balch CM, Shanafelt TD. Work-home conflicts have a substantial impact on career decisions that affect the adequacy of the surgical workforce. Arch Surg. 2012 Oct; 147(10):933-9.
    View PubMed
  50. Swetz KM, Shanafelt TD, Drozdowicz LB, Sloan JA, Novotny PJ, Durst LA, Frantz RP, McGoon MD. Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey. J Heart Lung Transplant. 2012 Oct; 31(10):1102-8.
    View PubMed
  51. Solberg Nes L, Liu H, Patten CA, Rausch SM, Sloan JA, Garces YI, Cheville AL, Yang P, Clark MM. Physical activity level and quality of life in long term lung cancer survivors. Lung Cancer. 2012 Sep; 77(3):611-6. Epub 2012 Jun 06.
    View PubMed
  52. Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, Sloan JA. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993). Support Care Cancer. 2012 Aug; 20(8):1729-35. Epub 2011 Sep 16.
    View PubMed
  53. Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, Sloan JA. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993). Support Care Cancer. 2012 Aug; 20(8):1729-35. Epub 2011 Sep 16.
    View PubMed
  54. Reriani M, Biehl M, Sloan JA, Malinchoc M, Gajic O. Effect of 24-hour mandatory vs on-demand critical care specialist presence on long-term survival and quality of life of critically ill patients in the intensive care unit of a teaching hospital. J Crit Care. 2012 Aug; 27(4):421.e1-7. Epub 2011 Dec 14.
    View PubMed
  55. Dyrbye LN, Harper W, Moutier C, Durning SJ, Power DV, Massie FS, Eacker A, Thomas MR, Satele D, Sloan JA, Shanafelt TD. A multi-institutional study exploring the impact of positive mental health on medical students' professionalism in an era of high burnout. Acad Med. 2012 Aug; 87(8):1024-31.
    View PubMed
  56. Dyar S, Lesperance M, Shannon R, Sloan J, Colon-Otero G. A nurse practitioner directed intervention improves the quality of life of patients with metastatic cancer: results of a randomized pilot study. J Palliat Med. 2012 Aug; 15(8):890-5. Epub 2012 May 04.
    View PubMed
  57. Rausch SM, Gonzalez BD, Clark MM, Patten C, Felten S, Liu H, Li Y, Sloan J, Yang P. SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors. Lung Cancer. 2012 Jul; 77(1):217-23. Epub 2012 Mar 29.
    View PubMed
  58. Gharacholou SM, Roger VL, Lennon RJ, Rihal CS, Sloan JA, Spertus JA, Singh M. Comparison of frail patients versus nonfrail patients >/=65 years of age undergoing percutaneous coronary intervention. Am J Cardiol. 2012 Jun 1; 109(11):1569-75. Epub 2012 Mar 20.
    View PubMed
  59. Sloan JA, de Andrade M, Decker P, Wampfler J, Oswold C, Clark M, Yang P. Genetic variations and patient-reported quality of life among patients with lung cancer. J Clin Oncol. 2012 May 10; 30(14):1699-704. Epub 2012 Mar 26.
    View PubMed
  60. Sloan JA, Zhao X, Novotny PJ, Wampfler J, Garces Y, Clark MM, Yang P. Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol. 2012 May 1; 30(13):1498-504. Epub 2012 Mar 26.
    View PubMed
  61. Kadakia KC, Barton DL, Loprinzi CL, Sloan JA, Otley CC, Diekmann BB, Novotny PJ, Alberts SR, Limburg PJ, Pittelkow MR. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251). Cancer. 2012 Apr 15; 118(8):2128-37. Epub 2011 Aug 31.
    View PubMed
  62. Shanafelt TD, Oreskovich MR, Dyrbye LN, Satele DV, Hanks JB, Sloan JA, Balch CM. Avoiding burnout: the personal health habits and wellness practices of US surgeons. Ann Surg. 2012 Apr; 255(4):625-33.
    View PubMed
  63. Bingener J, Sloan JA, Ghosh K, McConico A, Mariani A. Qualitative and quantitative analysis of women's perceptions of transvaginal surgery. Surg Endosc. 2012 Apr; 26(4):998-1004. Epub 2011 Nov 02.
    View PubMed
  64. Segal BM, Pogatchnik B, Holker E, Liu H, Sloan J, Rhodus N, Moser KL. Primary Sjogren's syndrome: cognitive symptoms, mood, and cognitive performance. Acta Neurol Scand. 2012 Apr; 125(4):272-8. Epub 2011 Jun 09.
    View PubMed
  65. Wolf SL, Barton DL, Qin R, Wos EJ, Sloan JA, Liu H, Aaronson NK, Satele DV, Mattar BI, Green NB, Loprinzi CL. The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer. 2012 Mar; 20(3):625-32. Epub 2011 Apr 12.
    View PubMed
  66. Frost MH, Johnson ME, Atherton PJ, Petersen WO, Dose AM, Kasner MJ, Burger KN, Sloan JA, Pipe TB. Spiritual well-being and quality of life of women with ovarian cancer and their spouses. J Support Oncol. 2012 Mar-Apr; 10(2):72-80. Epub 2011 Dec 14.
    View PubMed
  67. Oreskovich MR, Kaups KL, Balch CM, Hanks JB, Satele D, Sloan J, Meredith C, Buhl A, Dyrbye LN, Shanafelt TD. Prevalence of alcohol use disorders among American surgeons. Arch Surg. 2012 Feb; 147(2):168-74.
    View PubMed
  68. Yang P, Cheville AL, Wampfler JA, Garces YI, Jatoi A, Clark MM, Cassivi SD, Midthun DE, Marks RS, Aubry MC, Okuno SH, Williams BA, Nichols FC, Trastek VF, Sugimura H, Sarna L, Allen MS, Deschamps C, Sloan JA. Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol. 2012 Jan; 7(1):64-70.
    View PubMed
  69. Pachman DR, Barton DL, Clayton AC, McGovern RM, Jefferies JA, Novotny PJ, Sloan JA, Loprinzi CL, Gostout BS. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia. Am J Obstet Gynecol. 2012 Jan; 206(1):42.e1-7. Epub 2011 Jul 13.
    View PubMed
  70. Basch E, Abernethy A, Mullins CD, Spencer M, Brunner J, Chauhan C, Coons SJ, Eppard W, Frank ES, Lipscomb J, Raymon S, Reeve B, Sloan J, Smith ML, Tunis S, Wenzel K, Wheeler J. Effectiveness Guidance Document: Recommendations for incorporating patient-reported outcomes (PROs) into clinical comparative effectiveness research (CER) in adult oncology. Center for Medical Technology Policy. 2012.
  71. Dyrbye LN, Eacker AM, Harper W, Power DV, Massie FS Jr, Satele D, Thomas MR, Sloan JA, Shanafelt TD. Distress and empathy do not drive changes in specialty preference among US medical students. Med Teach. 2012; 34(2):e116-22.
    View PubMed
  72. Mittal MK, Sloan JA, Rabinstein AA. Facebook: can it be a diagnostic tool for neurologists? BMJ Case Rep. 2012; 2012. Epub 2012 Aug 21.
    View PubMed
  73. Balch CM, Oreskovich MR, Dyrbye LN, Colaiano JM, Satele DV, Sloan JA, Shanafelt TD. Personal consequences of malpractice lawsuits on American surgeons. J Am Coll Surg. 2011 Nov; 213(5):657-67. Epub 2011 Sep 03.
    View PubMed
  74. Reed DA, Shanafelt TD, Satele DW, Power DV, Eacker A, Harper W, Moutier C, Durning S, Massie FS Jr, Thomas MR, Sloan JA, Dyrbye LN. Relationship of pass/fail grading and curriculum structure with well-being among preclinical medical students: a multi-institutional study. Acad Med. 2011 Nov; 86(11):1367-73.
    View PubMed
  75. Kottschade LA, Sloan JA, Mazurczak MA, Johnson DB, Murphy BP, Rowland KM, Smith DA, Berg AR, Stella PJ, Loprinzi CL. The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer. 2011 Nov; 19(11):1769-77. Epub 2010 Oct 09.
    View PubMed
  76. Neben-Wittich MA, Atherton PJ, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Loprinzi CL, Burger KN, Martenson JA, Miller RC. Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). Int J Radiat Oncol Biol Phys. 2011 Oct 1; 81(2):397-402. Epub 2010 Oct 01.
    View PubMed
  77. Jatoi A, Dakhil SR, Sloan JA, Kugler JW, Rowland KM Jr, Schaefer PL, Novotny PJ, Wender DB, Gross HM, Loprinzi CL, North Central Cancer Treatment Group. Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB). Support Care Cancer. 2011 Oct; 19(10):1601-7. Epub 2010 Sep 6
    View PubMed
  78. Juhn YJ, Beebe TJ, Finnie DM, Sloan J, Wheeler PH, Yawn B, Williams AR. Development and initial testing of a new socioeconomic status measure based on housing data. J Urban Health. 2011 Oct; 88(5):933-44.
    View PubMed
  79. Eton DT, Bauer BA, Sood A, Yost KJ, Sloan JA. Patient-reported outcomes in studies of complementary and alternative medicine: problems, solutions, and future directions. Explore (NY). 2011 Sep-Oct; 7(5):314-9.
    View PubMed
  80. Stucky CC, Pockaj BA, Novotny PJ, Sloan JA, Sargent DJ, O'Connell MJ, Beart RW, Skibber JM, Nelson H, Weeks JC. Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Ann Surg Oncol. 2011 Sep; 18(9):2422-31. Epub 2011 Mar 31.
    View PubMed
  81. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. J Pain Symptom Manage. 2011 Aug; 42(2):213-21. Epub 2011 Mar 12.
    View PubMed
  82. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer. J Pain Symptom Manage. 2011 Aug; 42(2):202-12. Epub 2011 Mar 12.
    View PubMed
  83. Dyrbye LN, West CP, Satele D, Sloan JA, Shanafelt TD. Work/Home conflict and burnout among academic internal medicine physicians. Arch Intern Med. 2011 Jul 11; 171(13):1207-9.
    View PubMed
  84. Dyrbye LN, Schwartz A, Downing SM, Szydlo DW, Sloan JA, Shanafelt TD. Efficacy of a brief screening tool to identify medical students in distress. Acad Med. 2011 Jul; 86(7):907-14.
    View PubMed
  85. Loprinzi CL, Balcueva EP, Liu H, Sloan JA, Kottschade LA, Stella PJ, Carlson MD, Moore DF Jr, Zon RT, Levitt R, Jaslowski AJ. A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA. J Support Oncol. 2011 May-Jun; 9(3):105-12.
    View PubMed
  86. Palesh O, Demark-Wahnefried W, Mustian K, Minasian L, Rowland J, Sprod L, Janelsins M, Peppone L, Sloan J, Engquist KB, Jones L, Buist D, Paskett ED. Conducting cancer control and survivorship research via cooperative groups: a report from the American Society of Preventive Oncology. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):1050-5. Epub 2011 Apr 18.
    View PubMed
  87. Pachman DR, Swetz KM, Mauck WD, Pingree MJ, Hoelzer BC, Haugland AJ, Novotny PJ, Sloan JA, Moynihan TJ, Rho RH. An exploratory pilot study of palliative medicine compared to anesthesia-pain consultation for pain in patients with cancer. J Support Oncol. 2011 May-Jun; 9(3):113-9.
    View PubMed
  88. Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A, Le-Lindqwister NA, Soori GS, Jaslowski AJ, Novotny PJ, Lachance DH. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol. 2011 Apr 10; 29(11):1472-8. Epub 2011 Mar 07.
    View PubMed
  89. Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Stoffel TJ, Haselow RE, Schaefer PL, Bearden JD 3rd, Atherton PJ, Loprinzi CL, Martenson JA. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. 2011 Apr 1; 79(5):1460-6. Epub 2010 Aug 26.
    View PubMed
  90. Butterfield MC, Williams AR, Beebe T, Finnie D, Liu H, Liesinger J, Sloan J, Wheeler PH, Yawn B, Juhn YJ. A two-county comparison of the HOUSES index on predicting self-rated health. J Epidemiol Community Health. 2011 Mar; 65(3):254-9 Epub 2010 May 3.
    View PubMed
  91. Grothey A, Nikcevich DA, Sloan JA, Kugler JW, Silberstein PT, Dentchev T, Wender DB, Novotny PJ, Chitaley U, Alberts SR, Loprinzi CL. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol. 2011 Feb 1; 29(4):421-7. Epub 2010 Dec 28.
    View PubMed
  92. Dyrbye LN, Shanafelt TD, Balch CM, Satele D, Sloan J, Freischlag J. Relationship between work-home conflicts and burnout among American surgeons: a comparison by sex. Arch Surg. 2011 Feb; 146(2):211-7.
    View PubMed
  93. Steensma DP, Sloan JA, Dakhil SR, Dalton R, Kahanic SP, Prager DJ, Stella PJ, Rowland KM Jr, Novotny PJ, Loprinzi CL. Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. J Clin Oncol. 2011 Jan 1; 29(1):97-105. Epub 2010 Nov 22.
    View PubMed
  94. Shanafelt TD, Balch CM, Dyrbye L, Bechamps G, Russell T, Satele D, Rummans T, Swartz K, Novotny PJ, Sloan J, Oreskovich MR. Special report: suicidal ideation among American surgeons. Arch Surg. 2011 Jan; 146(1):54-62.
    View PubMed
  95. Sloan JA. Metrics to assess quality of life after management of early-stage lung cancer. Cancer J. 2011 Jan-Feb; 17(1):63-7.
    View PubMed
  96. Balch CM, Shanafelt TD, Sloan J, Satele DV, Kuerer HM. Burnout and career satisfaction among surgical oncologists compared with other surgical specialties. Ann Surg Oncol. 2011 Jan; 18(1):16-25. Epub 2010 Oct 15.
    View PubMed
  97. Barton DL, Atherton PJ, Bauer BA, Moore DF Jr, Mattar BI, Lavasseur BI, Rowland KM Jr, Zon RT, Lelindqwister NA, Nagargoje GG, Morgenthaler TI, Sloan JA, Loprinzi CL. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5). J Support Oncol. 2011 Jan-Feb; 9(1):24-31.
    View PubMed
  98. Kamal AH, Swetz KM, Carey EC, Cheville AL, Liu H, Ruegg SR, Moynihan TJ, Sloan JA, Kaur JS. Palliative care consultations in patients with cancer: a Mayo Clinic 5-year review. J Oncol Pract. 2011 Jan; 7(1):48-53.
    View PubMed
  99. Thicke LA, Hazelton JK, Bauer BA, Chan CW, Huntoon EA, Novotny PJ, Sloan JA, Wahner-Roedler DL. Acupuncture for treatment of noncyclic breast pain: a pilot study. Am J Chin Med. 2011; 39(6):1117-29.
    View PubMed
  100. Dyrbye LN, Harper W, Durning SJ, Moutier C, Thomas MR, Massie FS Jr, Eacker A, Power DV, Szydlo DW, Sloan JA, Shanafelt TD. Patterns of distress in US medical students. Med Teach. 2011; 33(10):834-9.
    View PubMed
  101. Dyrbye LN, Moutier C, Durning SJ, Massie FS Jr, Power DV, Eacker A, Harper W, Thomas MR, Satele D, Sloan JA, Shanafelt TD. The problems program directors inherit: medical student distress at the time of graduation. Med Teach. 2011; 33(9):756-8.
    View PubMed
  102. Sprangers MA, Sloan JA, Barsevick A, Chauhan C, Dueck AC, Raat H, Shi Q, Van Noorden CJ, GENEQOL Consortium. Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res. 2010 Dec; 19(10):1395-403. Epub 2010 Oct 14.
    View PubMed
  103. Balch CM, Shanafelt TD, Dyrbye L, Sloan JA, Russell TR, Bechamps GJ, Freischlag JA. Surgeon distress as calibrated by hours worked and nights on call. J Am Coll Surg. 2010 Nov; 211(5):609-19. Epub 2010 Sep 20.
    View PubMed
  104. Miller RC, Atherton PJ, Kabat BF, Fredericksen MB, Geno DM, Deschamps C, Jatoi A, Sloan JA, Romero Y. Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study. Dig Dis Sci. 2010 Oct; 55(10):2860-8. Epub 2010 Jan 22.
    View PubMed
  105. Dyrbye LN, Power DV, Massie FS, Eacker A, Harper W, Thomas MR, Szydlo DW, Sloan JA, Shanafelt TD. Factors associated with resilience to and recovery from burnout: a prospective, multi-institutional study of US medical students. Med Educ. 2010 Oct; 44(10):1016-26.
    View PubMed
  106. Dyrbye LN, Massie FS Jr, Eacker A, Harper W, Power D, Durning SJ, Thomas MR, Moutier C, Satele D, Sloan J, Shanafelt TD. Relationship between burnout and professional conduct and attitudes among US medical students. JAMA. 2010 Sep 15; 304(11):1173-80.
    View PubMed
  107. Rausch SM, Clark MM, Patten C, Liu H, Felten S, Li Y, Sloan J, Yang P. Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer. 2010 Sep 1; 116(17):4103-13.
    View PubMed
  108. Singh JA, Sloan JA, Atherton PJ, Smith T, Hack TF, Huschka MM, Rummans TA, Clark MM, Diekmann B, Degner LF. Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale. Am J Manag Care. 2010 Sep; 16(9):688-96.
    View PubMed
  109. Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, Suh JJ, Griffin PC, Johnson DB, Ali A, Silberstein PT, Duane SF, Loprinzi CL. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol. 2010 Aug 10; 28(23):3673-9. Epub 2010 Jul 12.
    View PubMed
  110. Cheville AL, Girardi J, Clark MM, Rummans TA, Pittelkow T, Brown P, Hanson J, Atherton P, Johnson ME, Sloan JA, Gamble G. Therapeutic exercise during outpatient radiation therapy for advanced cancer: Feasibility and impact on physical well-being. Am J Phys Med Rehabil. 2010 Aug; 89(8):611-9.
    View PubMed
  111. Barton DL, LaVasseur BI, Sloan JA, Stawis AN, Flynn KA, Dyar M, Johnson DB, Atherton PJ, Diekmann B, Loprinzi CL. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol. 2010 Jul 10; 28(20):3278-83. Epub 2010 May 24.
    View PubMed
  112. Shanafelt TD, Balch CM, Bechamps G, Russell T, Dyrbye L, Satele D, Collicott P, Novotny PJ, Sloan J, Freischlag J. Burnout and medical errors among American surgeons. Ann Surg. 2010 Jun; 251(6):995-1000.
    View PubMed
  113. Barsevick AM, Cleeland CS, Manning DC, O'Mara AM, Reeve BB, Scott JA, Sloan JA, ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes). ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010 Jun; 39(6):1086-99.
    View PubMed
  114. Cleeland CS, Sloan JA, ASCPRO Organizing Group. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards. J Pain Symptom Manage. 2010 Jun; 39(6):1077-85.
    View PubMed
  115. Sprangers MAG, Bartels M, Veenhoven R, Baas F, Martin NG, Mosing M, Movsas B, Ropka ME, Shinozaki G, Swaab D, The GENEQOL Consortium. Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states. Qual Life Res. 2010 Apr 24. [Epub ahead of print]
  116. Hines SL, Sloan JA, Atherton PJ, Perez EA, Dakhil SR, Johnson DB, Reddy PS, Dalton RJ, Mattar BI, Loprinzi CL. Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy. Breast. 2010 Apr; 19(2):92-6. Epub 2010 Jan 15.
    View PubMed
  117. Novotny P, Colligan RC, Szydlo DW, Clark MM, Rausch S, Wampfler J, Sloan JA, Yang P. A pessimistic explanatory style is prognostic for poor lung cancer survival. J Thorac Oncol. 2010 Mar; 5(3):326-32.
    View PubMed
  118. Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010 Feb 1; 70(3):875-82. Epub 2010 Jan 26.
    View PubMed
  119. Barton DL, Soori GS, Bauer BA, Sloan JA, Johnson PA, Figueras C, Duane S, Mattar B, Liu H, Atherton PJ, Christensen B, Loprinzi CL. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer. 2010 Feb; 18(2):179-87. Epub 2009 May 06.
    View PubMed
  120. Croghan IT, Hurt RD, Ebbert JO, Croghan GA, Polk OD, Stella PJ, Novotny PJ, Sloan J, Loprinzi CL. Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States. Z Gesundh Wiss. 2010 Feb; 18(1):59-68. Epub 2009 Aug 11.
    View PubMed
  121. Singh J, Sloan JA, Johanson NA. Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg. 2010 Feb; 18(2):72-82.
    View PubMed
  122. Dyrbye LN, Thomas MR, Power DV, Durning S, Moutier C, Massie FS Jr, Harper W, Eacker A, Szydlo DW, Sloan JA, Shanafelt TD. Burnout and serious thoughts of dropping out of medical school: a multi-institutional study. Acad Med. 2010 Jan; 85(1):94-102.
    View PubMed
  123. Dyrbye LN, Szydlo DW, Downing SM, Sloan JA, Shanafelt TD. Development and preliminary psychometric properties of a well-being index for medical students. BMC Med Educ. 2010; 10:8. Epub 2010 Jan 27.
    View PubMed
  124. Jatoi A, Thrower A, Sloan JA, Flynn PJ, Wentworth-Hartung NL, Dakhil SR, Mattar BI, Nikcevich DA, Novotny P, Sekulic A, Loprinzi CL. Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4). Oncologist. 2010; 15(9):1016-22. Epub 2010 Aug 26.
    View PubMed
  125. Thakur SJ, Trillo-Alvarez CA, Malinchoc MM, Kashyap R, Thakur L, Ahmed A, Reriani MK, Cartin-Ceba R, Sloan JA, Gajic O. Towards the prevention of acute lung injury: a population based cohort study protocol. BMC Emerg Med. 2010; 10:8. Epub 2010 Apr 27.
    View PubMed
  126. Novotny PJ, Smith DJ, Guse L, Rummans TA, Hartmann L, Alberts S, Goldberg R, Gregory D, Johnson M, Sloan JA. A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults. Cancer Manag Res. 2010; 2:133-42. Epub 2010 May 27.
    View PubMed
  127. Habermann TM, Thompson CA, LaPlant BR, Bauer BA, Janney CA, Clark MM, Rummans TA, Maurer MJ, Sloan JA, Geyer SM, Cerhan JR. Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol. 2009 Dec; 84(12):795-8.
    View PubMed
  128. West CP, Dyrbye LN, Sloan JA, Shanafelt TD. Single item measures of emotional exhaustion and depersonalization are useful for assessing burnout in medical professionals. J Gen Intern Med. 2009 Dec; 24(12):1318-21. Epub 2009 Oct 03.
    View PubMed
  129. Hines SL, Mincey B, Dentchev T, Sloan JA, Perez EA, Johnson DB, Schaefer PL, Alberts S, Liu H, Kahanic S, Mazurczak MA, Nikcevich DA, Loprinzi CL. Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC. Breast Cancer Res Treat. 2009 Oct; 117(3):603-9. Epub 2009 Feb 12.
    View PubMed
  130. West CP, Tan AD, Habermann TM, Sloan JA, Shanafelt TD. Association of resident fatigue and distress with perceived medical errors. JAMA. 2009 Sep 23; 302(12):1294-300.
    View PubMed
  131. Mesa RA, Schwager S, Radia D, Cheville A, Hussein K, Niblack J, Pardanani AD, Steensma DP, Litzow MR, Rivera CE, Camoriano J, Verstovsek S, Sloan J, Harrison C, Kantarjian H, Tefferi A. The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis. Leuk Res. 2009 Sep; 33(9):1199-203. Epub 2009 Feb 27.
    View PubMed
  132. Singh JA, Sloan J. Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty. Clin Rheumatol. 2009 Sep; 28(9):1025-33. Epub 2009 Jun 11.
    View PubMed
  133. Shanafelt TD, Balch CM, Bechamps GJ, Russell T, Dyrbye L, Satele D, Collicott P, Novotny PJ, Sloan J, Freischlag JA. Burnout and career satisfaction among American surgeons. Ann Surg. 2009 Sep; 250(3):463-71.
    View PubMed
  134. Loprinzi CL, Diekmann B, Novotny PJ, Stearns V, Sloan JA. Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Menopause. 2009 Sep-Oct; 16(5):883-7.
    View PubMed
  135. Qi Y, Schild SE, Mandrekar SJ, Tan AD, Krook JE, Rowland KM, Garces YI, Soori GS, Adjei AA, Sloan JA. Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. J Thorac Oncol. 2009 Sep; 4(9):1075-82.
    View PubMed
  136. Johnson ME, Dose AM, Pipe TB, Petersen WO, Huschka M, Gallenberg MM, Peethambaram P, Sloan J, Frost MH. Centering prayer for women receiving chemotherapy for recurrent ovarian cancer: a pilot study. Oncol Nurs Forum. 2009 Jul; 36(4):421-8.
    View PubMed
  137. Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol. 2009 Jun 10; 27(17):2831-7. Epub 2009 Mar 30.
    View PubMed
  138. Pockaj BA, Degnim AC, Boughey JC, Gray RJ, McLaughlin SA, Dueck AC, Perez EA, Halyard MY, Frost MH, Cheville AL, Sloan JA. Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol. 2009 Jun 1; 99(7):447-55.
    View PubMed
  139. Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E, ISPOR ePRO Task Force. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health. 2009 Jun; 12(4):419-29. Epub 2008 Nov 11
    View PubMed
  140. Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet. 2009 Jun; 12(3):301-11.
    View PubMed
  141. Shanafelt TD, West CP, Sloan JA, Novotny PJ, Poland GA, Menaker R, Rummans TA, Dyrbye LN. Career fit and burnout among academic faculty. Arch Intern Med. 2009 May 25; 169(10):990-5.
    View PubMed
  142. Bardia A, Novotny P, Sloan J, Barton D, Loprinzi C. Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis. Menopause. 2009 May-Jun; 16(3):477-83.
    View PubMed
  143. Yang P, Mandrekar SJ, Hillman SH, Allen Ziegler KL, Sun Z, Wampfler JA, Cunningham JM, Sloan JA, Adjei AA, Perez E, Jett JR. Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study. J Thorac Oncol. 2009 Apr; 4(4):479-85.
    View PubMed
  144. Yang P, Mandrekar SJ, Hillman SH, Allen Ziegler KL, Sun Z, Wampfler JA, Cunningham JM, Sloan JA, Adjei AA, Perez E, Jett JR. Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study. J Thorac Oncol. 2009 Apr; 4(4):479-85.
    View PubMed
  145. Cheville AL, Sloan JA, Northfelt DW, Jillella AP, Wong GY, Bearden Iii Jd, Liu H, Schaefer PL, Marchello BT, Christensen BJ, Loprinzi CL. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support Care Cancer. 2009 Apr; 17(4):451-60. Epub 2009 Jan 13.
    View PubMed
  146. Hines SL, Mincey BA, Sloan JA, Thomas SP, Chottiner E, Loprinzi CL, Carlson MD, Atherton PJ, Salim M, Perez EA. Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol. 2009 Mar 1; 27(7):1047-53. Epub 2008 Dec 15.
    View PubMed
  147. Dyrbye LN, Thomas MR, Harper W, Massie FS Jr, Power DV, Eacker A, Szydlo DW, Novotny PJ, Sloan JA, Shanafelt TD. The learning environment and medical student burnout: a multicentre study. Med Educ. 2009 Mar; 43(3):274-82.
    View PubMed
  148. Shanafelt TD, Bowen DA, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Tun H, Sloan JA, Call TG. The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res. 2009 Feb; 33(2):263-70. Epub 2008 Jul 25.
    View PubMed
  149. Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Wolf S. Newer antidepressants for hot flashes--should their efficacy still be up for debate? Menopause. 2009 Jan-Feb; 16(1):184-7.
    View PubMed
  150. Dyrbye Ln, Sloan JA, Shanafelt TD. Is there a connection between high educational debt and suicidal ideation among medical students? Annals of Internal Medicine. 2009; 150(4):285.
  151. Mincey B, Dentchev T, Sloan J, Hines S, Perez E, Johnson D, Schaefer P, Alberts S, Liu H, Wender D, Mazurczak M, Nikcevich D, Loprinzi C. Immediate vs. Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letrozole After Tamoxifen - N03CC. Breast Cancer Res Treat. 2009; 117:603-9.
    View PubMed
  152. Singh JA, Sloan JA. Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplasty. Rheumatology (Oxford) 2008 Dec; 47(12):1826-31. Epub 2008 Oct 16.
    View PubMed
  153. Martenson JA, Halyard MY, Sloan JA, Proulx GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai TH, Zhu AW, Keit J, Stien KJ, Atherton PJ. Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. J Clin Oncol. 2008 Nov 10; 26(32):5248-53. Epub 2008 Sep 02.
    View PubMed
  154. Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, Beer TM. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer. 2008 Oct 15; 113(8):2205-14.
    View PubMed
  155. Grothey A, Adjei AA, Alberts SR, Perez EA, Jaeckle KA, Loprinzi CL, Sargent DJ, Sloan JA, Buckner JC, North Central Cancer Treatment Group. North Central Cancer Treatment Group--achievements and perspectives. Semin Oncol. 2008 Oct; 35(5):530-44.
    View PubMed
  156. Dyrbye LN, Thomas MR, Massie FS, Power DV, Eacker A, Harper W, Durning S, Moutier C, Szydlo DW, Novotny PJ, Sloan JA, Shanafelt TD. Burnout and suicidal ideation among U.S. medical students. Ann Intern Med. 2008 Sep 2; 149(5):334-41.
    View PubMed
  157. Jatoi A, Rowland K, Sloan JA, Gross HM, Fishkin PA, Kahanic SP, Novotny PJ, Schaefer PL, Johnson DB, Tschetter LK, Loprinzi CL. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Cancer. 2008 Aug 15; 113(4):847-53.
    View PubMed
  158. Clark MM, Novotny PJ, Patten CA, Rausch SM, Garces YI, Jatoi A, Sloan JA, Yang P. Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer. 2008 Jul; 61(1):117-22. Epub 2008 Feb 19.
    View PubMed
  159. Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Dakhil SR, Verdirame JD, Knutson WH, Kelaghan J, Christensen B. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause. 2008 Jul-Aug; 15(4 Pt 1):655-60.
    View PubMed
  160. Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M, Loprinzi CL. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer. 2008 Jun 15; 112(12):2802-8.
    View PubMed
  161. Steensma DP, Heptinstall KV, Johnson VM, Novotny PJ, Sloan JA, Camoriano JK, Niblack J, Bennett JM, Mesa RA. Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey. Leuk Res. 2008 May; 32(5):691-8. Epub 2007 Dec 4
    View PubMed
  162. Okuno SH, Delaune R, Sloan JA, Foster NR, Maurer MJ, Aubry MC, Rowland KM Jr, Soori GS, Nikcevich DA, Kardinal CG, Northfelt DW, Adjei AA, North Central Cancer Treatment Group. A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021. Cancer. 2008 Apr 15; 112(8):1772-9.
    View PubMed
  163. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008 Feb; 61(2):102-9. Epub 2007 Aug 03.
    View PubMed
  164. Thompson S, Bardia A, Tan A, Barton DL, Kottschade L, Sloan JA, Christensen B, Smith D, Loprinzi CL. Levetiracetam for the treatment of hot flashes: a phase II study. Support Care Cancer. 2008 Jan; 16(1):75-82. Epub 2007 Jun 28.
    View PubMed
  165. Croghan G, Croghan I, Hurt R, Kaur J, Novotny P, Sloan J, DeKrey W, Steen P, Loprinzi C. A Comparison by Ethnicity of a 15 Mg/16 Hour Nicotine Patch Alone Versus Nicotine Nasal Spray Alone Verus Both. J Health Care for the Poor and Underserved. 2008.
    View PubMed
  166. Okuno S, Delaune R, Sloan J, Foster N, Maurer M, Aubry M, Rowland K, Soori G, Nikcevich D, Kardinal C, Northfelt D, Adjei A A Phase II Study of Gemcitabine and Epirubicin for the Treatment of Pleural Mesothelioma: A North Central Cancer Treatment Study, N0021 Cancer. 2008; 112:1772 - 1779.
    View PubMed
  167. Cheville A, Sloan J, Northfelt D, Jillella A, Wong G, Bearden J, Liu H, Schaefer P, Marchello B, Christensen B, Loprinzi C. The Efficacy of Lidocaine Patch in the Management of Postsurgical Neuropathic Pain in Patients with Cancer: A Phase III Double-Blind, Crossover Study (N01CB). J Pain Symp Manag. 2008.
    View PubMed
  168. Petersen LR, Clark MM, Novotny P, Kung S, Sloan JA, Patten CA, Vickers KS, Rummans TA, Frost MH, Colligan RC. Relationship of optimism-pessimism and health-related quality of life in breast cancer survivors. J Psychosoc Oncol. 2008; 26(4):15-32.
    View PubMed
  169. Sochocki MP, Verity S, Atherton PJ, Huntington JL, Sloan JA, Embil JM, Trepman E. Health related quality of life in patients with Charcot arthropathy of the foot and ankle. Foot Ankle Surg. 2008; 14(1):11-5. Epub 2007 Oct 22.
    View PubMed
  170. Jatoi A, Novotny P, Cassivi S, Clark MM, Midthun D, Patten CA, Sloan J, Yang P. Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort. Oncologist. 2007 Dec; 12(12):1456-63.
    View PubMed
  171. Locke DE, Decker PA, Sloan JA, Brown PD, Malec JF, Clark MM, Rummans TA, Ballman KV, Schaefer PL, Buckner JC. Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage. 2007 Dec; 34(6):628-38. Epub 2007 Aug 20.
    View PubMed
  172. Bruner DW, Bryan CJ, Aaronson N, Blackmore CC, Brundage M, Cella D, Ganz PA, Gotay C, Hinds PS, Kornblith AB, Movsas B, Sloan J, Wenzel L, Whalen G, National Cancer Institute. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol. 2007 Nov 10; 25(32):5051-7.
    View PubMed
  173. Sloan JA, Berk L, Roscoe J, Fisch MJ, Shaw EG, Wyatt G, Morrow GR, Dueck AC, National Cancer Institute. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol. 2007 Nov 10; 25(32):5070-7.
    View PubMed
  174. Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Kutteh LA, Wong GY, North Central Cancer Treatment Group. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer. 2007 Nov 1; 110(9):2110-8.
    View PubMed
  175. Snyder CF, Watson ME, Jackson JD, Cella D, Halyard MY, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcome instrument selection: designing a measurement strategy. Value Health. 2007 Nov-Dec; 10 Suppl 2:S76-85.
    View PubMed
  176. Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, Santanello NC, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Interpreting and reporting results based on patient-reported outcomes. Value Health. 2007 Nov-Dec; 10 Suppl 2:S116-24.
    View PubMed
  177. Sloan JA, Halyard MY, Frost MH, Dueck AC, Teschendorf B, Rothman ML. The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. Value Health. 2007 Nov-Dec; 10(Suppl 2):S59-63.
    View PubMed
  178. Dueck AC, Sloan JA. Meeting on the FDA draft guidance on patient-reported outcomes. Value Health. 2007 Nov-Dec; 10 Suppl 2:S64-5.
    View PubMed
  179. Sloan JA, Dueck AC, Erickson PA, Guess H, Revicki DA, Santanello NC, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Analysis and interpretation of results based on patient-reported outcomes. Value Health. 2007 Nov-Dec; 10 Suppl 2:S106-15.
    View PubMed
  180. Kuerer HM, Eberlein TJ, Pollock RE, Huschka M, Baile WF, Morrow M, Michelassi F, Singletary SE, Novotny P, Sloan J, Shanafelt TD. Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol. 2007 Nov; 14(11):3043-53. Epub 2007 Sep 09.
    View PubMed
  181. Dyrbye LN, Thomas MR, Eacker A, Harper W, Massie FS Jr, Power DV, Huschka M, Novotny PJ, Sloan JA, Shanafelt TD. Race, ethnicity, and medical student well-being in the United States. Arch Intern Med. 2007 Oct 22; 167(19):2103-9.
    View PubMed
  182. Frost MH, Bonomi AE, Cappelleri JC, Schunemann HJ, Moynihan TJ, Aaronson NK, Clinical Significance Consensus Meeting Group. Applying quality-of-life data formally and systematically into clinical practice. Mayo Clin Proc. 2007 Oct; 82(10):1214-28.
    View PubMed
  183. Guyatt GH, Ferrans CE, Halyard MY, Revicki DA, Symonds TL, Varricchio CG, Kotzeva A, Valderas JM, Alonso JL, Clinical Significance Consensus Meeting Group. Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clin Proc. 2007 Oct; 82(10):1229-39.
    View PubMed
  184. Hahn EA, Cella D, Chassany O, Fairclough DL, Wong GY, Hays RD, Clinical Significance Consensus Meeting Group. Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc. 2007 Oct; 82(10):1244-54.
    View PubMed
  185. Shanafelt TD, Bowen D, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Sloan JA, Call TG. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol. 2007 Oct; 139(2):255-64.
    View PubMed
  186. Johnson ME, Piderman KM, Sloan JA, Huschka M, Atherton PJ, Hanson JM, Brown PD, Rummans TA, Clark MM, Frost MH. Measuring spiritual quality of life in patients with cancer. J Support Oncol. 2007 Oct; 5(9):437-42.
    View PubMed
  187. Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM Jr, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer. 2007 Sep 15; 110(6):1396-403.
    View PubMed
  188. Barton DL, Loprinzi CL, Atherton P, Raymond J, Shanafelt T, Hines S, Palmieri F, Rummans T, Adjei AA, Sloan J. Phase II Evaluation of Desipramine for the Treatment of Hot Flashes. Support Cancer Ther. 2007 Sep 1; 4(4):219-24.
    View PubMed
  189. Mularski RA, Rosenfeld K, Coons SJ, Dueck A, Cella D, Feuer DJ, Lipscomb J, Karpeh MS Jr, Mosich T, Sloan JA, Krouse RS. Measuring outcomes in randomized prospective trials in palliative care. J Pain Symptom Manage. 2007 Jul; 34(1 Suppl):S7-S19. Epub 2007 May 25.
    View PubMed
  190. O'dwyer PJ, Eckhardt SG, Haller DG, Tepper J, Ahnen D, Hamilton S, Benson AB 3rd, Rothenberg M, Petrelli N, Lenz HJ, Diasio R, DuBois R, Sargent D, Sloan J, Johnson CD, Comis RL, O'Connell MJ, Gastrointestinal Scientific Leadership Council of the Coalitio Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. J Clin Oncol. 2007 Jun 1; 25(16):2313-21.
    View PubMed
  191. Pruthi S, Thompson SL, Novotny PJ, Barton DL, Kottschade LA, Tan AD, Sloan JA, Loprinzi CL. Pilot evaluation of flaxseed for the management of hot flashes. J Soc Integr Oncol. 2007 Summer; 5(3):106-12.
    View PubMed
  192. West CP, Huntington JL, Huschka MM, Novotny PJ, Sloan JA, Kolars JC, Habermann TM, Shanafelt TD. A prospective study of the relationship between medical knowledge and professionalism among internal medicine residents. Acad Med. 2007 Jun; 82(6):587-92.
    View PubMed
  193. Lapid MI, Rummans TA, Brown PD, Frost MH, Johnson ME, Huschka MM, Sloan JA, Richardson JW, Hanson JM, Clark MM. Improving the quality of life of geriatric cancer patients with a structured multidisciplinary intervention: a randomized controlled trial. Palliat Support Care. 2007 Jun; 5(2):107-14.
    View PubMed
  194. Barton DL, Wender DB, Sloan JA, Dalton RJ, Balcueva EP, Atherton PJ, Bernath AM Jr, DeKrey WL, Larson T, Bearden JD 3rd, Carpenter PC, Loprinzi CL. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst. 2007 May 2; 99(9):672-9.
    View PubMed
  195. Perez DG, Zahasky KM, Loprinzi CL, Sloan J, Novotny P, Barton D, Pritchard KI. Tamoxifen-associated hot flashes in women. Support Cancer Ther. 2007 May 1; 4(3):152-6.
    View PubMed
  196. Haddock MG, Sloan JA, Bollinger JW, Soori G, Steen PD, Martenson JA, North Central Cancer Treatment Group. Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial. J Clin Oncol. 2007 Apr 1; 25(10):1255-9.
    View PubMed
  197. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67(5):1318-22.
    View PubMed
  198. Teschendorf B, Schwartz C, Ferrans CE, O'Mara A, Novotny P, Sloan J. Caregiver role stress: when families become providers. Cancer Control. 2007 Apr; 14(2):183-9.
    View PubMed
  199. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol. 2007 Mar; 5(3):119-25, 128.
    View PubMed
  200. Huschka MM, Mandrekar SJ, Schaefer PL, Jett JR, Sloan JA. A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Cancer. 2007 Feb 15; 109(4):787-95.
    View PubMed
  201. Croghan IT, Hurt RD, Dakhil SR, Croghan GA, Sloan JA, Novotny PJ, Rowland KM, Bernath A, Loots ML, Le-Lindqwister NA, Tschetter LK, Garneau SC, Flynn KA, Ebbert LP, Wender DB, Loprinzi CL. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc. 2007 Feb; 82(2):186-95.
    View PubMed
  202. Thomas MR, Dyrbye LN, Huntington JL, Lawson KL, Novotny PJ, Sloan JA, Shanafelt TD. How do distress and well-being relate to medical student empathy? A multicenter study. J Gen Intern Med. 2007 Feb; 22(2):177-83.
    View PubMed
  203. Mesa RA, Niblack J, Wadleigh M, Verstovsek S, Camoriano J, Barnes S, Tan AD, Atherton PJ, Sloan JA, Tefferi A. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs) - an international internet-based survey of 1179 MPD patients. Cancer. 2007 Jan 1; 109(1):68-76.
    View PubMed
  204. Revicki DA, Sloan J. Practical and philosophical issues surrounding a national item bank: if we build it will they come? Qual Life Res. 2007; 16 Suppl 1:167-74 Epub 2007 Apr 28.
    View PubMed
  205. Miller JJ, Frost MH, Rummans TA, Huschka M, Atherton P, Brown P, Gamble G, Richardson J, Hanson J, Sloan JA, Clark MM. Role of a medical social worker in improving quality of life for patients with advanced cancer with a structured multidisciplinary intervention. J Psychosoc Oncol. 2007; 25(4):105-19.
    View PubMed
  206. Dyrbye LN, Thomas MR, Eacker A, Harper W, Massie Jr FS, Power DV, Huschka M, Novotny PJ, Sloan JA, Shanafelt TD. The association of race with medical student well-being across the United States. Arch Intern Med. 2007; 167:2103-9.
  207. Kung S, Rummans TA, Colligan RC, Clark MM, Sloan JA, Novotny PJ, Huntington JL. Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers. Mayo Clin Proc. 2006 Dec; 81(12):1545-52.
    View PubMed
  208. Sloan JA, Zhao CX. Genetics and quality of life. Curr Probl Cancer. 2006 Nov-Dec; 30(6):255-60.
    View PubMed
  209. Halyard MY, Frost MH, Dueck A, Sloan JA. Is the use of QOL data really any different than other medical testing? Curr Probl Cancer. 2006 Nov-Dec; 30(6):261-71.
    View PubMed
  210. Callstrom MR, Atwell TD, Charboneau JW, Farrell MA, Goetz MP, Rubin J, Sloan JA, Novotny PJ, Welch TJ, Maus TP, Wong GY, Brown KJ. Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis. Radiology. 2006 Nov; 241(2):572-80.
    View PubMed
  211. Dyrbye LN, Thomas MR, Huschka MM, Lawson KL, Novotny PJ, Sloan JA, Shanafelt TD. A multicenter study of burnout, depression, and quality of life in minority and nonminority US medical students. Mayo Clin Proc. 2006 Nov; 81(11):1435-42.
    View PubMed
  212. Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D, Clinical Significance Consensus Meeting Group. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer. 2006 Oct; 14(10):988-98. Epub 2006 Jun 23.
    View PubMed
  213. West CP, Huschka MM, Novotny PJ, Sloan JA, Kolars JC, Habermann TM, Shanafelt TD. Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study. JAMA. 2006 Sep 6; 296(9):1071-8.
    View PubMed
  214. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol. 2006 Fall; 4(4):143-52.
    View PubMed
  215. Bradley EA, Sloan JA, Novotny PJ, Garrity JA, Woog JJ, West SK. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy. Ophthalmology. 2006 Aug; 113(8):1450-4. Epub 2006 Jun 12.
    View PubMed
  216. Pitot HC, Adjei AA, Reid JM, Sloan JA, Atherton PJ, Rubin J, Alberts SR, Duncan BA, Denis L, Schaaf LJ, Yin D, Sharma A, McGovren P, Miller LL, Erlichman C. A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2006 Aug; 58(2):165-72. Epub 2005 Nov 19.
    View PubMed
  217. Bardia A, Thompson S, Atherton PJ, Barton DL, Sloan JA, Kottschade LA, Christensen B, Collins M, Loprinzi CL. Pilot evaluation of aprepitant for the treatment of hot flashes. Support Cancer Ther. 2006 Jul 1; 3(4):240-6.
    View PubMed
  218. Clark MM, Hurt RD, Croghan IT, Patten CA, Novotny P, Sloan JA, Dakhil SR, Croghan GA, Wos EJ, Rowland KM, Bernath A, Morton RF, Thomas SP, Tschetter LK, Garneau S, Stella PJ, Ebbert LP, Wender DB, Loprinzi CL. The prevalence of weight concerns in a smoking abstinence clinical trial. Addict Behav. 2006 Jul; 31(7):1144-52. Epub 2005 Aug 30.
    View PubMed
  219. Alberts SR, Novotny PJ, Sloan JA, Danella J, Bostwick DG, Sebo TJ, Blute ML, Fitch TR, Levitt R, Lieberman R, Loprinzi CL. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial. Am J Ther. 2006 Jul-Aug; 13(4):291-7.
    View PubMed
  220. Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol. 2006 Jun 20; 24(18):2836-41.
    View PubMed
  221. Perez DG, Loprinzi CL, Sloan J, Novotny P, Barton D, Carpenter L, Smith D, Christensen B, Rummans T. Pilot evaluation of bupropion for the treatment of hot flashes. J Palliat Med. 2006 Jun; 9(3):631-7.
    View PubMed
  222. Clark MM, Rummans TA, Sloan JA, Jensen A, Atherton PJ, Frost MH, Richardson JW, Bostwick JM, Johnson ME, Hanson JM, Brown PD. Quality of life of caregivers of patients with advanced-stage cancer. Am J Hosp Palliat Care. 2006 Jun-Jul; 23(3):185-91.
    View PubMed
  223. Sideras K, Schaefer PL, Okuno SH, Sloan JA, Kutteh L, Fitch TR, Dakhil SR, Levitt R, Alberts SR, Morton RF, Rowland KM, Novotny PJ, Loprinzi CL. Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial. Mayo Clin Proc. 2006 Jun; 81(6):758-67.
    View PubMed
  224. Dyrbye LN, Thomas MR, Huntington JL, Lawson KL, Novotny PJ, Sloan JA, Shanafelt TD. Personal life events and medical student burnout: a multicenter study. Acad Med. 2006 Apr; 81(4):374-84.
    View PubMed
  225. Goodridge D, Trepman E, Sloan J, Guse L, Strain LA, McIntyre J, Embil JM. Quality of life of adults with unhealed and healed diabetic foot ulcers. Foot Ankle Int. 2006 Apr; 27(4):274-80.
    View PubMed
  226. Loprinzi CL, Levitt R, Barton D, Sloan JA, Dakhil SR, Nikcevich DA, Bearden JD 3rd, Mailliard JA, Tschetter LK, Fitch TR, Kugler JW. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol. 2006 Mar 20; 24(9):1409-14. Epub 2006 Feb 27.
    View PubMed
  227. Steensma DP, Molina R, Sloan JA, Nikcevich DA, Schaefer PL, Rowland KM Jr, Dentchev T, Novotny PJ, Tschetter LK, Alberts SR, Hogan TF, Law A, Loprinzi CL. Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer. J Clin Oncol. 2006 Mar 1; 24(7):1079-89.
    View PubMed
  228. Hassan I, Cima RC, Sloan JA. Assessment of quality of life outcomes in the treatment of advanced colorectal malignancies. Gastroenterol Clin North Am. 2006 Mar; 35(1):53-64.
    View PubMed
  229. Rummans TA, Clark MM, Sloan JA, Frost MH, Bostwick JM, Atherton PJ, Johnson ME, Gamble G, Richardson J, Brown P, Martensen J, Miller J, Piderman K, Huschka M, Girardi J, Hanson J. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol. 2006 Feb 1; 24(4):635-42.
    View PubMed
  230. Baxter NN, Novotny PJ, Jacobson T, Maidl LJ, Sloan J, Young-Fadok TM. A stoma quality of life scale. Dis Colon Rectum. 2006 Feb; 49(2):205-12.
    View PubMed
  231. Brown P, Clark MM, Atherton P, Huschka M, Sloan JA, Gamble G, Girardi J, Frost MH, Piderman K, Rummans TA. Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer? Am J Clin Oncol. 2006 Feb; 29(1):52-8.
    View PubMed
  232. Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, Gupta L, Tang-Wai DF, Arusell RM, Clark MM, Buckner JC. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006 Feb; 76(3):283-91.
    View PubMed
  233. Barton DL, Loprinzi C, Atherton PJ, Kottschade L, Collins M, Carpenter P, Adjei A, Rummans TA, Shanafelt T, Christensen B, Sloan J. Dehydroepiandrosterone for the treatment of hot flashes: a pilot study. Support Cancer Ther. 2006 Jan 1; 3(2):91-7.
    View PubMed
  234. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes. 2006; 4:70. Epub 2006 Sep 27.
    View PubMed
  235. Frost MH, Slezak JM, Tran NV, Williams CI, Johnson JL, Woods JE, Petty PM, Donohue JH, Grant CS, Sloan JA, Sellers TA, Hartmann LC. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol. 2005 Nov 1; 23(31):7849-56.
    View PubMed
  236. Sloan JA. Challenges in QOL assessment. Overview and introduction. Curr Probl Cancer. 2005 Nov-Dec; 29(6):274-7.
    View PubMed
  237. Jatoi A, Giordano KF, Nguyen PL, Sloan J, Hartmann LC. Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group. Support Cancer Ther. 2005 Oct 1; 3(1):59-62.
    View PubMed
  238. Loprinzi CL, Flynn PJ, Carpenter LA, Atherton P, Barton DL, Shanafelt TD, Rummans TA, Sloan JA, Adjei AA, Mincey BA, Fitch TR, Collins M. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med. 2005 Oct; 8(5):924-30.
    View PubMed
  239. Molina JR, Reid JM, Erlichman C, Sloan JA, Furth A, Safgren SL, Lathia CD, Alberts SR. A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin. Anticancer Drugs. 2005 Oct; 16(9):997-1002.
    View PubMed
  240. Kaufmann SH, Karp JE, Letendre L, Kottke TJ, Safgren S, Greer J, Gojo I, Atherton P, Svingen PA, Loegering DA, Litzow MR, Sloan JA, Reid JM, Ames MM, Adjei AA, Erlichman C. Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia. Clin Cancer Res. 2005 Sep 15; 11(18):6641-9.
    View PubMed
  241. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, Boeve BF, Arusell RM, Clark MM, Buckner JC. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery. 2005 Sep; 57(3):495-504; discussion 495-504.
    View PubMed
  242. Bible KC, Lensing JL, Nelson SA, Lee YK, Reid JM, Ames MM, Isham CR, Piens J, Rubin SL, Rubin J, Kaufmann SH, Atherton PJ, Sloan JA, Daiss MK, Adjei AA, Erlichman C. Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points. Clin Cancer Res. 2005 Aug 15; 11(16):5935-41.
    View PubMed
  243. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF Jr, Krook JE, Rowland KM Jr, Mazurczak MA, Berg AR, Kim GP, North Central Cancer Treatment Group. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer. 2005 Jul 1; 104(1):176-82.
    View PubMed
  244. Shanafelt TD, West C, Zhao X, Novotny P, Kolars J, Habermann T, Sloan J. Relationship between increased personal well-being and enhanced empathy among internal medicine residents. J Gen Intern Med. 2005 Jul; 20(7):559-64.
    View PubMed
  245. Meyerhardt JA, Sloan JA, Sargent DJ, Goldberg RM, Pollak M, Morton RF, Ramanathan RK, Williamson SK, Findlay BP, Fuchs CS. Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1402-10.
    View PubMed
  246. Dy GK, Suri A, Reid JM, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Atherton PJ, Hanson LJ, Burch PA, Rubin J, Erlichman C, Adjei AA. A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors. Cancer Chemother Pharmacol. 2005 Jun; 55(6):522-30. Epub 2005 Mar 08.
    View PubMed
  247. Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA, Rowland KM, Alberts SR, Krook JE, Levitt R, Morton RF. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol. 2005 Apr 20; 23(12):2606-17. Epub 2004 Sep 27.
    View PubMed
  248. Sloan JA. Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions. COPD. 2005 Mar; 2(1):57-62.
    View PubMed
  249. Galanis E, Okuno SH, Nascimento AG, Lewis BD, Lee RA, Oliveira AM, Sloan JA, Atherton P, Edmonson JH, Erlichman C, Randlev B, Wang Q, Freeman S, Rubin J. Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas. Gene Ther. 2005 Mar; 12(5):437-45.
    View PubMed
  250. Goetz MP, Toft D, Reid J, Ames M, Stensgard B, Safgren S, Adjei AA, Sloan J, Atherton P, Vasile V, Salazaar S, Adjei A, Croghan G, Erlichman C. Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. J Clin Oncol. 2005 Feb 20; 23(6):1078-87.
    View PubMed
  251. Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, Petersen RC. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Support Care Cancer. 2005 Jan; 13(1):66-9. Epub 2004 Oct 09.
    View PubMed
  252. Dispenzieri A, Wiseman GA, Lacy MQ, Litzow MR, Anderson PM, Gastineau DA, Tefferi A, Inwards DJ, Micallef IN, Ansell SM, Porrata L, Elliott MA, Lust JA, Greipp PR, Rajkumar SV, Fonseca R, Witzig TE, Erlichman C, Sloan JA, Gertz MA. A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma. Leukemia. 2005 Jan; 19(1):118-25.
    View PubMed
  253. Shanafelt TD, Novotny P, Johnson ME, Zhao X, Steensma DP, Lacy MQ, Rubin J, Sloan J. The well-being and personal wellness promotion strategies of medical oncologists in the North Central Cancer Treatment Group. Oncology. 2005; 68(1):23-32. Epub 2005 Mar 16.
    View PubMed
  254. Sloan JA. QOL SOS: Quality of Life State of the Science: an editorial series. Journal of Cancer Pain and Symptom Palliation. 2005; 1(1):95-98.
  255. Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T, Clinical Significance Consensus Meeting Group. Estimating clinically significant differences in quality of life outcomes. Qual Life Res. 2005; 14:285-95.
    View PubMed
  256. Sloan JA, Scott-Findlay S, Nemecek A, Blood P, Trylinski C, Whittaker H, El Sayed S, Clinch J, Khoo K. Mapping the journey of cancer patients through the health care system, Part 3: an approach to staging. Canadian Oncology Nursing Journal. 2005: 4-8.
  257. Sloan J, Frost M, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D The Clinical Significance of Quality of Life Assessments in Oncology: A Summary for Clinicians Cancer. 2005.
    View PubMed
  258. Sloan J, Collign R, Piderman K Quality of Life Spirituality and Mayo Franciscan Values: A Research Perspective. Mayo Clin Proc. 2005.
    View PubMed
  259. Croghan I, Sloan J, Hurt R, Croghan G, Dakhil S, Novotny P, Schroeder D, Wos E, Rowland K, Nair S Perceived quality of life among smokers in smoking cessation therapy Journal of the Society for Integrative Oncology. 2005.
    View PubMed
  260. Brown P, Ballman K, Rummans T, Maurer M, Sloan J, Boeve B, Gupta L, Tang-Wai D, Arusell R, Clark M, Buckner J Prospective study of quality of life in adults with newly diagnosed high-grade glioma: A North Central Cancer Treatment Group trial. J Neuro-Oncol. 2005.
    View PubMed
  261. Okuno S, Foote R, Olmscheid M, Sloan J, Sapiente R, Novotny P, Anthes M, Loprinzi C An Evaluation of an Oral Capsaicin Lozenge for Preventing Radiation-Induced Mucoxtitis J of Cancer Integrative Medicine. 2005; 2:179-183.
    View PubMed
  262. Dy GK, Bekele L, Hanson LJ, Furth A, Mandrekar S, Sloan JA, Adjei AA. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol. 2004 Dec 1; 22(23):4758-63.
    View PubMed
  263. Jatoi A, Jett JR, Sloan J, Novotny P, Ford J, Prabhakar U, Loprinzi CL. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Support Care Cancer. 2004 Dec; 12(12):859-63. Epub 2004 Sep 15.
    View PubMed
  264. Garces YI, Yang P, Parkinson J, Zhao XH, Wampfler JA, Ebbert JO, Sloan JA. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004 Dec; 126(6):1733-41.
    View PubMed
  265. Loprinzi CL, Barton DL, Carpenter LA, Sloan JA, Novotny PJ, Gettman MT, Christensen BJ. Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clin Proc. 2004 Oct; 79(10):1247-51.
    View PubMed
  266. Jatoi A, Egner J, Loprinzi CL, Sloan JA, Novotny PJ, Dakhil SR, Mailliard JA, Klee GG, Krook JE. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer. 2004 Sep; 12(9):640-4.
    View PubMed
  267. Sloan JA, Scott-Findlay S, Nemecek A, Blood P, Trylinski C, Whittaker H, El Sayed S, Clinch J, Khoo K. Mapping the journey of cancer patients through the health care system. Part 2: Methodological approaches and basic findings. Can Oncol Nurs J. 2004 Fall; 14(4):224-32.
    View PubMed
  268. Svobodnik A, Yang P, Novotny PJ, Bass E, Garces YI, Jett JR, Bonner JA, Sloan JA. Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis. Mayo Clin Proc. 2004 Aug; 79(8):1024-30.
    View PubMed
  269. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B, North Central Cancer Treatment Group. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004 Jun 15; 22(12):2469-76.
    View PubMed
  270. Sloan JA, Scott-Findlay S, Nemecek A, Blood P, Trylinski C, Whittaker H, El Sayed S, Clinch J, Khoo K. Mapping the journey of cancer patients through health care system. Part 1: developing the research question. Can Oncol Nurs J. 2004 Summer; 14(3):183-6, 188-91.
    View PubMed
  271. Shanafelt TD, Loprinzi C, Marks R, Novotny P, Sloan J. Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer? J Clin Oncol. 2004 May 15; 22(10):1966-74.
    View PubMed
  272. Kaur JS, Roubidoux MA, Sloan J, Novotny P. Can the Gail model be useful in American Indian and Alaska Native populations? Cancer. 2004 Mar 1; 100(5):906-12.
    View PubMed
  273. Sloan JA, Dueck A. Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Stat. 2004 Feb; 14(1):73-96.
    View PubMed
  274. Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, Wong GY, Sloan JA, Novotny PJ, Petersen IA, Beres RA, Regge D, Capanna R, Saker MB, Gronemeyer DHW, Gevargez A, Ahrar K, Choti MA, de Baere TJ, Rubin J. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: A multicenter study. J Clin Oncol. 2004 Jan 15; 22(2):300-6.
    View PubMed
  275. Perez DG, Loprinzi CL, Barton DL, Pockaj BA, Sloan J, Novotny PJ, Christensen BJ. Pilot evaluation of mirtazapine for the treatment of hot flashes. J Support Oncol. 2004 Jan-Feb; 2(1):50-6.
    View PubMed
  276. Norman GR, Sloan JA, Wyrwich KW. The truly remarkable universality of half a standard deviation: confirmation through another look. Expert Review of Pharmacoeconomics and Outcomes Research. 2004; 4(5):581-5.
  277. Jatoi A, Ellison N, Burch PA, Quesenberry J, Shogren K, Sloan JA, Young CYF. Prostate cancer patients with maspin-negative tumors can live over a decade. Cancer Therapy. 2004; 2:173-6.
  278. Witzig T, Silberstein P, Loprinzi C, Sloan J, Novotny P, Mailliard J, Rowland K, Alberts S, Nikcevich D, Levitt R, Morton R A Phase III Randomized Double-Blind Study of Epoetin alfa Versus Placebo in Anemic Patients with Cancer Undergoing Chemotherapy J Clin Oncol. 2004; 22:1-12.
    View PubMed
  279. Roubidoux M, Kaur J, Griffiths K, Novotny P, Stillwater B, Sloan J A pilot study of the relationship of mammographic parenchymal patterns with breast cancer risk factors and smoking in Alaska Native women Cancer Epidemiology Biomarkers and Prevention. 2004.
    View PubMed
  280. Lindor NM, Sloan J, Goldberg R, Bowen D, Nigon S, Roche A, Petersen G, Thibodeau SN, Burgart L, Leontovich O, Morlan BW. Colorectal tumour microsatellite instability test results: perspectives from patients. Hered Cancer Clin Pract. 2004; 2(2):69-75. Epub 2004 May 15.
    View PubMed
  281. Okuno SH, Foote RL, Olmscheid MA, Sloan JA, Sapiente RA, Novotny PJ, Anthes ML, Loprinzi CL. Evaluation of an oral capsaicin lozenge for preventing radiation-induced mucositis. Journal of Cancer Integrative Medicine. 2004; 2(4):179-83.
    View PubMed
  282. Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang H, Lambert GH, Reeser KA, Wisbey JA. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest. 2004; 22(4):515-21.
    View PubMed
  283. Gill P, Kaur JS, Rummans T, Novotny PJ, Sloan JA. The hospice patient's primary caregiver. What is their quality of life? J Psychosom Res. 2003 Nov; 55(5):445-51.
    View PubMed
  284. Jacobson SD, Loprinzi CL, Sloan JA, Wilke JL, Novotny PJ, Okuno SH, Jatoi A, Moynihan TJ. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol. 2003 Nov-Dec; 1(4):274-8.
    View PubMed
  285. Goetz MP, Erlichman C, Windebank AJ, Reid JM, Sloan JA, Atherton P, Adjei AA, Rubin J, Pitot H, Galanis E, Ames MM, Goldberg RM. Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors. J Clin Oncol. 2003 Oct 15; 21(20):3761-9. Epub 2003 Sep 08.
    View PubMed
  286. Marks RS, Graham DL, Sloan JA, Hillman S, Fishkoff S, Krook JE, Okuno SH, Mailliard JA, Fitch TR, Addo F. A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer. Am J Clin Oncol. 2003 Aug; 26(4):336-7.
    View PubMed
  287. Adjei AA, Croghan GA, Erlichman C, Marks RS, Reid JM, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Bruzek LM, Atherton P, Thibault A, Palmer PA, Kaufmann SH. A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer. Clin Cancer Res. 2003 Jul; 9(7):2520-6.
    View PubMed
  288. Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. A phase II study of topical ceramides for cutaneous breast cancer. Breast Cancer Res Treat. 2003 Jul; 80(1):99-104.
    View PubMed
  289. Jatoi A, Hillman S, Stella PJ, Mailliard JA, Sloan J, Vanone S, Cannon MW, Kutteh L, Kanard A, Jett JR. Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer. 2003 Jul; 11(7):460-4.
    View PubMed
  290. Giuntoli RL, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003 Jun; 89(3):460-9.
    View PubMed
  291. Schaefer PL, Marks RS, Mahoney MR, Sloan JA, Bauman MD, Tazelaar HD, Kugler JW, Mailliard JA, Ebbert LP, Wiesenfeld M. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers. Am J Clin Oncol. 2003 Jun; 26(3):236-40.
    View PubMed
  292. Roubidoux MA, Kaur JS, Griffith KA, Sloan J, Wilson C, Novotny P, Lobell M. Correlates of mammogram density in southwestern Native-American women. Cancer Epidemiol Biomarkers Prev. 2003 Jun; 12(6):552-8.
    View PubMed
  293. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol. 2003 May 1; 21(9 Suppl):79s-81s.
    View PubMed
  294. Kozelsky TF, Meyers GE, Sloan JA, Shanahan TG, Dick SJ, Moore RL, Engeler GP, Frank AR, McKone TK, Urias RE, Pilepich MV, Novotny PJ, Martenson JA, North Central Cancer Treatment Group. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol. 2003 May 1; 21(9):1669-74.
    View PubMed
  295. Barton DL, Loprinzi CL, Novotny P, Shanafelt T, Sloan J, Wahner-Roedler D, Rummans TA, Christensen B, Dakhill SR, Martin LS. Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol. 2003 May-Jun; 1(1):47-51.
    View PubMed
  296. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003 May; 41(5):582-92.
    View PubMed
  297. Norman GR, Sloan JA, Wyrwich KW. Is it simple or simplistic? Med Care. 2003 May; 41(5):599-600.
    View PubMed
  298. Shanafelt TD, Sloan JA, Habermann TM. The well-being of physicians. Am J Med. 2003 Apr 15; 114(6):513-9.
    View PubMed
  299. Croghan GA, Sloan JA, Croghan IT, Novotny P, Hurt RD, DeKrey WL, Mailliard JA, Ebbert LP, Swan DK, Walsh DJ, Wiesenfeld M, Levitt R, Stella P, Johnson PA, Tschetter LK, Loprinzi C. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine Tob Res. 2003 Apr; 5(2):181-7.
    View PubMed
  300. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer. 2003 Mar 15; 97(6):1442-6.
    View PubMed
  301. Hurt RD, Krook JE, Croghan IT, Loprinzi CL, Sloan JA, Novotny PJ, Kardinal CG, Knost JA, Tirona MT, Addo F, Morton RF, Michalak JC, Schaefer PL, Porter PA, Stella PJ. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J Clin Oncol. 2003 Mar 1; 21(5):914-20.
    View PubMed
  302. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Sloan JA, Sykes AM, Aughenbaugh GL, Clemens MA. Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003 Mar; 226(3):756-61.
    View PubMed
  303. Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli RL, McGovern RM, Sloan JA, Cha SS, Persing DH. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol. 2003 Mar; 88(3):326-32.
    View PubMed
  304. Adjei AA, Dy GK, Erlichman C, Reid JM, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Atherton PJ, Watanabe T, Geary RS, Holmlund J, Dorr FA. A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer. Clin Cancer Res. 2003 Jan; 9(1):115-23.
    View PubMed
  305. Witizig T, T S, Loprinzi C, Sloan J, Novotny P, Mailliard J, Rowland K, Levitt R, Morton R A Phase III Randomized Double-Blind Study of Epoetin alfa Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy J of Clin Oncol. 2003.
    View PubMed
  306. Jatoi A, Hillman S, Stella P, Mailliard J, Sloan J, Vanone S, Cannon M, Kutteh L, Kanard A, Jett J Activities of Daily Living: Exploring their Spectrum and Prognostic Impact in Older, Chemotherapy-Treated Lung Cancer Patients Supportive Care in Cancer. 2003; 7:460-464.
    View PubMed
  307. Sloan JA, Cella D, Frost MH, Guyatt G, Osoba D, Clinical Significance Consensus Meeting Group. Quality of life III: translating the science of quality-of-life assessment into clinical practice-an example-driven approach for practicing clinicians and clinical researchers. Clin Ther. 2003; 25 Suppl D:D1-5.
    View PubMed
  308. Sloan JA, Symonds T, Vargas-Chanes D, Fridley B. Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials. Drug Inf J. 2003; 37(1):23-31.
  309. Atherton PJ, Jasperson B, Nibbe A, Clement-Brown KA, Allmer C, Novotny P, Erlichman C, Sloan JA. What happened to all the patients? Event charts for summarizing individual patient data and displaying clinically significant changes in quality of life data. Drug Inf J. 2003; 37(1):11-21.
  310. Sloan JA, Vargas-Chanes D, Kamath CC, Sargent DJ, Novotny P, Atherton P, Allmer C, Fridley BL, Frost M, Loprinzi CL. Detecting worms, ducks, and elephants: A simple approach for defining clinically relevant effects in quality-of-life measures. Journal of Cancer Integrative Medicine. 2003; 1(1):41-7.
    View PubMed
  311. Hobday TJ, Kugler JW, Mahoney MR, Sargent DJ, Sloan JA, Fitch TR, Krook JE, O'Connell MJ, Mailliard JA, Tirona MT, Tschetter LK, Cobau CD, Goldberg RM. Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma. J Clin Oncol. 2002 Dec 1; 20(23):4574-80.
    View PubMed
  312. Barton D, Loprinzi C, Quella S, Sloan J, Pruthi S, Novotny P. Depomedroxyprogesterone acetate for hot flashes. J Pain Symptom Manage. 2002 Dec; 24(6):603-7.
    View PubMed
  313. Klein CE, Gupta E, Reid JM, Atherton PJ, Sloan JA, Pitot HC, Ratain MJ, Kastrissios H. Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide. Clinical Pharmacology & Therapeutics. 2002 Dec; 72(6):638-47.
    View PubMed
  314. Frost MH, Sloan JA. Quality of life measurements: a soft outcome - or is it? Am J Manag Care. 2002 Dec; 8(18 Suppl S):S574-9.
    View PubMed
  315. Loprinzi L, Barton DL, Sloan JA, Zahasky KM, Smith DA, Pruthi S, Novotny PJ, Perez EA, Christensen BJ. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc. 2002 Nov; 77(11):1159-63.
    View PubMed
  316. Cox LS, Sloan JA, Patten CA, Bonner JA, Geyer SM, McGinnis WL, Stella PJ, Marks RS. Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. Psychooncology. 2002 Nov-Dec; 11(6):472-8.
    View PubMed
  317. Goldberg RM, Kaufmann SH, Atherton P, Sloan JA, Adjei AA, Pitot HC, Alberts SR, Rubin J, Miller LL, Erlichman C. A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin. Ann Oncol. 2002 Oct; 13(10):1674-80.
    View PubMed
  318. Adjei AA, Reid JM, Erlichman C, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Ruben S, Boemer SA, Atherton P, Ames MM, Kaufmann SH. A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer. Invest New Drugs. 2002 Aug; 20(3):297-304.
    View PubMed
  319. Hammack JE, Michalak JC, Loprinzi CL, Sloan JA, Novotny PJ, Soori GS, Tirona MT, Rowland KM Jr, Stella PJ, Johnson JA. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain. 2002 Jul; 98(1-2):195-203.
    View PubMed
  320. Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Wong GY, Sloan JA, Novotny PJ, Lewis BD, Welch TJ, Farrell MA, Maus TP, Lee RA, Reading CC, Petersen IA, Pickett DD. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology. 2002 Jul; 224(1):87-97.
    View PubMed
  321. Sprangers MAG, Moinpour CM, Moynihan TJ, Patrick DL, Revicki DA, Clinical Significance Consensus Meeting Group. Assessing meaningful change in quality of life over time: A users' guide for clinicians. Mayo Clin Proc. 2002 Jun; 77(6):561-71.
    View PubMed
  322. Symonds T, Berzon R, Marquis P, Rummans TA, Clinical Significance Consensus Meeting Group. The clinical significance of quality-of-life results: practical considerations for specific audiences. Mayo Clin Proc. 2002 Jun; 77(6):572-83.
    View PubMed
  323. Cuddihy M, Gabriel SE, Sloan JA, Crowson CS, Melton LJ III. Osteoporosis health beliefs among postmenopausal women with a history of distal forearm fracture. Clinical Journal of Women's Health. 2002 Jun; 2(2):79-87.
    View PubMed
  324. Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C, Clinical Significance Consensus Meeting Group. Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc. 2002 May; 77(5):479-87.
    View PubMed
  325. Frost MH, Bonomi AE, Ferrans CE, Wong GY, Hays RD, Clinical Significance Consensus Meeting Group. Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clin Proc. 2002 May; 77(5):488-94.
    View PubMed
  326. Cella D, Bullinger M, Scott C, Barofsky I, Clinical Significance Consensus Meeting Group. Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clin Proc. 2002 Apr; 77(4):384-92.
    View PubMed
  327. Sloan JA, Cella D, Frost M, Guyatt GH, Sprangers M, Symonds T, Clinical Significance Consensus Meeting Group. Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc. 2002 Apr; 77(4):367-70.
    View PubMed
  328. Sloan JA, Goldberg RM, Sargent DJ, Vargas-Chanes D, Nair S, Cha SS, Novotny PJ, Poon MA, O'Connell MJ, Loprinzi CL. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol. 2002 Mar 15; 20(6):1491-8.
    View PubMed
  329. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002 Mar 15; 20(6):1578-83.
    View PubMed
  330. Adjei AA, Reid JM, Diasio RB, Sloan JA, Smith DA, Rubin J, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Atherton P, Ames MM, Erlichman C. Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors. J Clin Oncol. 2002 Mar 15; 20(6):1683-91.
    View PubMed
  331. Pitot HC, Reid JM, Sloan JA, Ames MM, Adjei AA, Rubin J, Bagniewski PG, Atherton P, Rayson D, Goldberg RM, Erlichman C. A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors. Clin Cancer Res. 2002 Mar; 8(3):712-7.
    View PubMed
  332. Yang P, Yokomizo A, Tazelaar HD, Marks RS, Lesnick TG, Miller DL, Sloan JA, Edell ES, Meyer RL, Jett J, Liu W. Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung Cancer. 2002 Mar; 35(3):221-9.
    View PubMed
  333. Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS, Clayton AC, Pairolero PC. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 2002 Feb 15; 165(4):508-13.
    View PubMed
  334. Sloan JA, Bonner JA, Hillman SL, Allmer C, Shanahan TG, Brooks BJ, Marks RS, Vargas-Chanes D, Jett JR. A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1). Int J Radiat Oncol Biol Phys. 2002 Feb 1; 52(2):371-81.
    View PubMed
  335. Sloan JA, Sargent DJ, Lindman J, Allmer C, Vargas-Chanes D, Creagan ET, Bonner JA, O'Connell MJ, Dalton RJ, Rowland KM, Brooks BJ, Laurie JA. A new graphic for quality adjusted life years (Q-TWiST) survival analysis: the Q-TWiST plot. Qual Life Res. 2002 Feb; 11(1):37-45.
    View PubMed
  336. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol. 2002 Jan 15; 20(2):567-73.
    View PubMed
  337. Ansell SM, Witzig TE, Kurtin PJ, Sloan JA, Jelinek DF, Howell KG, Markovic SN, Habermann TM, Klee GG, Atherton PJ, Erlichman C. Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma. Blood. 2002 Jan 1; 99(1):67-74.
    View PubMed
  338. Jatoi A, Yamashita J, Sloan JA, Novotny PJ, Windschitl HE, Loprinzi CL. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer. 2002 Jan; 10(1):71-5.
    View PubMed
  339. Barton D, La Vasseur B, Loprinzi C, Novotny P, Wilwerding MB, Sloan J. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum. 2002 Jan-Feb; 29(1):33-40.
    View PubMed
  340. Sloan JA, Bonner JA, Hillmann SL, Allmer C, Shanahan TG, Brooks BJ, Marks S, Vargas D, Jett JR. A quality-adjusted re-analysis of a phase III trial comparing once-daily thoracic radiation versus twice-daily thoracic radiation in patients with limited stage small cell lung cancer. Journal of Clinical Oncology. 2002; 52:371-81.
  341. Cox LC, Sloan JA, Patten CA, Bonner JA, Geyer SM, McGinnis WL, Stella PJ, Marks RS. Smoking behavior change of 226 patients with newly diagnosed stage IIIA/IIIB non-small cell lung cancer. Psycho-Oncology. 2002; 11:1-7.
    View PubMed
  342. Schroeder G, Sloan JA, Cha S, Atherton P, Allmer C, Erlichman C. Phase I oncology clinical trials for related subpopulations: the power walk design. Drug Information Journal. 2002; 36:581-93.
  343. Sloan JA, Cella D, Frost M, Guyatt GH, Sprangers M, Symonds T. Assessing the clinical significance of quality-of-life measures in oncology research: state of the science - overview. Clin Ther. 2002; 24(Suppl B):1-4.
  344. Marks R, Wiesenfeld M, Sloan J, Hillman S, Tazelaar H, Carroll T, Vukov A, Krook J, Buckner J, Marschke R, Schaefer P, Hatfield A. A Randomized Phase II Trial of TwoTopotecan-Based Combination Chemotherapy Regimens in Advanced Stage Non-Small Cell Lung Carcinoma Lung Cancer. 2002.
    View PubMed
  345. Marks R, Nair S, Mahoney M, Allmer C, Sloan J, Tazelaar H, Drevyanko T, Michalak J, Veeder M, Levitt R, Rowland K A Phase II Study of Paclitaxel and Cisplatin for Extensive Stage Small Cell Lung Cancers Lung Cancer. 2002.
    View PubMed
  346. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clinic Proc. 2002; 77:371-83.
    View PubMed
  347. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001 Dec 1; 19(23):4280-90.
    View PubMed
  348. Colon-Otero G, Niedringhaus RD, Hillman SH, Geyer S, Sloan J, Krook JE, Windschitl HE, Marks RS, Wiesenfeld M, Tschetter LK, Jett JJ, North Central Cancer Treatment Group. A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial. Am J Clin Oncol. 2001 Dec; 24(6):551-5.
    View PubMed
  349. Sloan JA, Atherton P, Reid J, Pitot HC, Erlichman C, Schaaf L. Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide. Cancer Chemother Pharmacol. 2001 Sep; 48(3):241-9.
    View PubMed
  350. Jatoi A, Loprinzi CL, Sloan JA, Klee GG, Windschitl HE. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer. 2001 Aug 1; 92(3):629-33.
    View PubMed
  351. Sloan JA, Loprinzi CL, Laurine JA, Novotny PJ, Vargas-Chanes D, Krook JE, O'Connell MJ, Kugler JW, Tirona MT, Kardinal CG, Wiesenfeld M, Tschetter LK, Hatfield AK, Schaefer PL. A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol. 2001 Aug 1; 19(15):3539-46.
    View PubMed
  352. O'Rourke DJ, Klaasen KS, Sloan JA. Redesigning nighttime care for personal care residents. J Gerontol Nurs. 2001 Jul; 27(7):30-7.
    View PubMed
  353. Alberts SR, Erlichman C, Sloan J, Okuno SH, Burch PA, Rubin J, Pitot HC, Goldberg RM, Adjei AA, Atherton PJ, Kaufmann SH. Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks. Ann Oncol. 2001 May; 12(5):627-31.
    View PubMed
  354. Galanis E, Goldberg R, Reid J, Atherton P, Sloan J, Pitot H, Rubin J, Adjei AA, Burch P, Safgren SL, Witzig TE, Ames MM, Erlichman C. Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd). Ann Oncol. 2001 May; 12(5):701-7.
    View PubMed
  355. Lee JJ, Lieberman R, Sloan JA, Piantadosi S, Lippman SM. Design considerations for efficient prostate cancer chemoprevention trials. Urology. 2001 Apr; 57(4 Suppl 1):205-12.
    View PubMed
  356. Sloan JA, Varricchio C. Quality of Life endpoints in prostate chemoprevention trials. Urology. 2001 Apr; 57(4 Suppl 1):235-40.
    View PubMed
  357. Erlichman C, Adjei AA, Alberts SR, Sloan JA, Goldberg RM, Pitot HC, Rubin J, Atherton PJ, Klee GG, Humphrey R. Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566. Ann Oncol. 2001 Mar; 12(3):389-95.
    View PubMed
  358. Sloan JA, Tolman DE, Anderson JD, Sugar AW, Wolfaardt JF, Novotny P. Patients with reconstruction of craniofacial or intraoral defects: development of instruments to measure quality of life. Int J Oral Maxillofac Implants. 2001 Mar-Apr; 16(2):225-45.
    View PubMed
  359. Dudgeon DJ, Kristjanson L, Sloan JA, Lertzman M, Clement K. Dyspnea in cancer patients: prevalence and associated factors. J Pain Symptom Manage. 2001 Feb; 21(2):95-102.
    View PubMed
  360. Sloan J, Bonner J, Hillman S, Allmer C, Shanahan T, Brooks B, Marks R, Vargas-Chanes D, Jett J A quality-adjusted re-analysis of a phase III trial comparing once-daily thoracic radiation in patients with limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys. 2001.
    View PubMed
  361. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, Novotny PJ, Dakhil SR, Rodger K, Rummans TA, Christensen BJ. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000 Dec 16; 356(9247):2059-63.
    View PubMed
  362. Rummans TA, Bostwick JM, Clark MM, Mayo Clinic Cancer Center Quality of Life Working Group. Maintaining quality of life at the end of life. Mayo Clin Proc. 2000 Dec; 75(12):1305-10.
    View PubMed
  363. Pangman VC, Sloan J, Guse L. An examination of psychometric properties of the mini-mental state examination and the standardized mini-mental state examination: implications for clinical practice. Appl Nurs Res. 2000 Nov; 13(4):209-13.
    View PubMed
  364. Rozich JD, D'Amore L, Sloan J. Physician-owned imaging centers: the future is now. Med Group Manage J. 2000 Sep-Oct; 47(5):48-53.
    View PubMed
  365. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol. 2000 Aug; 18(15):2930-2.
    View PubMed
  366. Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE, Petty PM, Johnson JL, Sitta DL, McDonnell SK, Rummans TA, Jenkins RB, Sloan JA, Hartmann LC. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. 2000 Jul 19; 284(3):319-24.
    View PubMed
  367. Pitot HC, Goldberg RM, Reid JM, Sloan JA, Skaff PA, Erlichman C, Rubin J, Burch PA, Adjei AA, Alberts SA, Schaaf LJ, Elfring G, Miller LL. Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy. Clin Cancer Res. 2000 Jun; 6(6):2236-44.
    View PubMed
  368. Weitz JJ, Marschke RF Jr, Sloan JA, Grill JP, Jett JR, Knost JA, Hatfield AK, Zenk DW, Bate WW, Schaefer PL. A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer. Lung Cancer. 2000 May; 28(2):157-62.
    View PubMed
  369. Sloan JA, Novotny PJ, Loprinzi CL. Design and analysis of cancer control studies using the SAS system. SUGI 25 Proceedings. 2000 Apr 9-12:259-25.
  370. Adjei AA, Erlichman C, Davis JN, Cutler DL, Sloan JA, Marks RS, Hanson LJ, Svingen PA, Atherton P, Bishop WR, Kirschmeier P, Kaufmann SH. A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity. Cancer Res. 2000 Apr 1; 60(7):1871-7.
    View PubMed
  371. Loprinzi CL, Zahasky KM, Sloan JA, Novotny PJ, Quella SK. Tamoxifen-induced hot flashes. Clin Breast Cancer. 2000 Apr; 1(1):52-6.
    View PubMed
  372. Adjei AA, Erlichman C, Sloan JA, Reid JM, Pitot HC, Goldberg RM, Peethambaram P, Atherton P, Hanson LJ, Alberts SR, Jett J. Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors. J Clin Oncol. 2000 Apr; 18(8):1748-57.
    View PubMed
  373. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol. 2000 Mar; 18(5):1068-74.
    View PubMed
  374. Adjei AA, Klein CE, Kastrissios H, Goldberg RM, Alberts SR, Pitot HC, Sloan JA, Reid JM, Hanson LJ, Atherton P, Rubin J, Erlichman C. Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity. J Clin Oncol. 2000 Mar; 18(5):1116-23.
    View PubMed
  375. Martenson JA, Bollinger JW, Sloan JA, Novotny PJ, Urias RE, Michalak JC, Shanahan TG, Mailliard JA, Levitt R. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial. J Clin Oncol. 2000 Mar; 18(6):1239-45.
    View PubMed
  376. Bonner JA, Sloan JA, Rowland KM Jr, Klee GG, Kugler JW, Mailliard JA, Wiesenfeld M, Krook JE, Maksymiuk AW, Shaw EG, Marks RS, Perez EA. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. Clin Cancer Res. 2000 Feb; 6(2):597-601.
    View PubMed
  377. Sloan JA, Loprinzi CL, Novotny PJ, Okuno S, Nair S, Barton DL. Sex differences in fluorouracil-induced stomatitis. J Clin Oncol. 2000 Jan; 18(2):412-20.
    View PubMed
  378. Martenson J, Bollinger J, Sloan J, Michalak J, Mailliard J, Levitt R, Novotny P, Urias R, Shanahan T Phase III double-blind placebo-controlled trial to assess the effectiveness of sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol. 2000; 18, No. 6:1239-1245.
    View PubMed
  379. Sloan J, Loprinzi C, Novotny P, Okuno S, Barton D, Nair S Gender differences in 5FU-induced stomatitis J Clin Oncol. 2000; 18(2):412-420.
    View PubMed
  380. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Rowland KM Jr, Camoriano JK, Novotny PJ, Christensen BJ. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol. 1999 Oct; 17(10):3299-306.
    View PubMed
  381. Anderson PM, Markovic SN, Sloan JA, Clawson ML, Wylam M, Arndt CA, Smithson WA, Burch P, Gornet M, Rahman E. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases. Clin Cancer Res. 1999 Sep; 5(9):2316-23.
    View PubMed
  382. Bonner JA, Sloan JA, Shanahan TG, Brooks BJ, Marks RS, Krook JE, Gerstner JB, Maksymiuk A, Levitt R, Mailliard JA, Tazelaar HD, Hillman S, Jett JR. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol. 1999 Sep; 17(9):2681-91.
    View PubMed
  383. Bretscher M, Rummans T, Sloan J, Kaur J, Bartlett A, Borkenhagen L, Loprinzi C. Quality of life in hospice patients. A pilot study. Psychosomatics. 1999 Jul-Aug; 40(4):309-13.
    View PubMed
  384. Quella SK, Loprinzi CL, Sloan J, Novotny P, Perez EA, Burch PA, Antolak SJ Jr, Pisansky TM. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol. 1999 Jul; 162(1):98-102.
    View PubMed
  385. Okuno SH, Woodhouse CO, Loprinzi CL, Sloan JA, LaVasseur BI, Clemens-Schutjer D, Swan D, Axvig C, Ebbert LP, Tirona MR, Michalak JC, Pierson N. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol. 1999 Jun; 22(3):258-61.
    View PubMed
  386. Sargent DJ, Sloan JA, Cha SS. Sample size and design considerations for phase II clinical trials with correlated observations. Control Clin Trials. 1999 Jun; 20(3):242-52.
    View PubMed
  387. Wagner JL, Alberts SR, Sloan JA, Cha S, Killian J, O'Connell MJ, Van Grevenhof P, Lindman J, Chute CG. Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst. 1999 May 19; 91(10):847-53.
    View PubMed
  388. Fonseca R, O'Neill BP, Foote RL, Grill JP, Sloan JA, Frytak S. Cerebral toxicity in patients treated for small cell carcinoma of the lung. Mayo Clin Proc. 1999 May; 74(5):461-5.
    View PubMed
  389. Galanis E, Frytak S, Rowland KM Jr, Sloan JA, Lennon VA. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy. Cancer Immunol Immunother. 1999 May-Jun; 48(2-3):85-90.
    View PubMed
  390. Pitot HC, McElroy EA Jr, Reid JM, Windebank AJ, Sloan JA, Erlichman C, Bagniewski PG, Walker DL, Rubin J, Goldberg RM, Adjei AA, Ames MM. Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors. Clin Cancer Res. 1999 Mar; 5(3):525-31.
    View PubMed
  391. Loprinzi CL, Kugler JW, Sloan JA, Rooke TW, Quella SK, Novotny P, Mowat RB, Michalak JC, Stella PJ, Levitt R, Tschetter LK, Windschitl H. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med. 1999 Feb 4; 340(5):346-50.
    View PubMed
  392. Marschke RF Jr, Grill JP, Sloan JA, Wender DB, Levitt R, Mailliard JA, Gerstner JB, Ghosh C, Morton RF, Jett JR. Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer. Am J Clin Oncol. 1999 Feb; 22(1):15-7.
    View PubMed
  393. Lobchuk MM, Kristjanson L, Degner L, Blood P, Sloan JA. Wahrnehmung der Symptombelastung bei Lungenkrebspatienten: I. Ubereinstimmung zwischen Patienten und den sie hauptsachlich pflegenden Angehorigen PFLEG. 1999; 12:352-61.
  394. Loprinzi CL, Johnston PB, Sloan JA, Novotny P, Ellison N. Have medical oncologists recently modified surveillance testing patterns for melanoma and/or breast cancer survivors? Cancer Research, Therapy & Control. 1999; 9(3-4):205-14.
  395. Mandrekar JN, Sargent DJ, Novotny PJ, Sloan JA. A general Gibbs sampling algorithm for analyzing linear models using SAS system. Proceedings of the 24th SAS Users Group International Conference (SUGI), Paper 266 1999:1540-5.
  396. Finck G, Barton DL, Loprinzi CL, Quella SK, Sloan JA. Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage. 1998 Nov; 16(5):327-33.
    View PubMed
  397. Sloan JA, Loprinzi CL, Kuross SA, Miser AW, O'Fallon JR, Mahoney MR, Heid IM, Bretscher ME, Vaught NL. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998 Nov; 16(11):3662-73.
    View PubMed
  398. Alberts SR, Erlichman C, Reid JM, Sloan JA, Ames MM, Richardson RL, Goldberg RM. Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks. Clin Cancer Res. 1998 Sep; 4(9):2111-7.
    View PubMed
  399. Loprinzi CL, Pisansky TM, Fonseca R, Sloan JA, Zahasky KM, Quella SK, Novotny PJ, Rummans TA, Dumesic DA, Perez EA. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol. 1998 Jul; 16(7):2377-81.
    View PubMed
  400. Quella SK, Loprinzi CL, Sloan JA, Vaught NL, DeKrey WL, Fischer T, Finck G, Pierson N, Pisansky T. Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer. 1998 May 1; 82(9):1784-8.
    View PubMed
  401. Bonner JA, McGinnis WL, Stella PJ, Marschke RF Jr, Sloan JA, Shaw EG, Mailliard JA, Creagan ET, Ahuja RK, Johnson PA. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study. Cancer. 1998 Mar 15; 82(6):1037-48.
    View PubMed
  402. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, Fidler P, Stella PJ, Swan DK, Vaught NL, Novotny P. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 1998 Feb; 16(2):495-500.
    View PubMed
  403. Goodridge DM, Sloan JA, DeDoyen YM, McKenzie J, Knight WE, Gayari M. Risk assessment scores, prevention strategies and the incidence of pressure ulcers among the elderly in four Canadian health care facilities. Canadian Journal of Nursing Research. 1998; 30:23-44.
    View PubMed
  404. Degner LF, Davison J, Sloan JA, Mueller B. Development of a scale to measure information needs in cancer care. Journal of Nursing Measurement. 1998; 6:137-53.
    View PubMed
  405. Atherton SP, Sloan JA. Design and analysis of equivalence trials via the SAS system Proceedings of SUGI. 1998; 23:1166-71.
  406. Sloan JA, Novotny PJ, Loprinzi CL. Analyzing quality of life data via the SAS system. SUGI. 1998; 23:1213-22.
  407. Sloan JA. How to consult with a statistician -- and live. American Statistical Association. Chance. 1998; 9(1).
  408. Sloan JA, Novotny PJ, Loprinzi CL. Analyzing Quality of Life (QOL) Endpoints in Clinical Trials via the SAS System. Statistics Data Analysis, and Modeling. 1998:1213-1222.
  409. Goldberg RM, Reid JM, Ames MM, Sloan JA, Rubin J, Erlichman C, Kuffel MJ, Fitch TR. Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2363-70.
    View PubMed
  410. Lobchuk MM, Kristjanson L, Degner L, Blood P, Sloan JA. Perceptions of symptom distress in lung cancer patients: I. Congruence between patients and primary family caregivers. J Pain Symptom Manage. 1997 Sep; 14(3):136-46.
    View PubMed
  411. Colon-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Cancer J Sci Am. 1997 Sep-Oct; 3(5):297-302.
    View PubMed
  412. Perez EA, Loprinzi CL, Sloan JA, Owens DT, Novotny PJ, Bonner JA. Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma. Cancer. 1997 Aug 15; 80(4):676-80.
    View PubMed
  413. Ellison N, Loprinzi CL, Kugler J, Hatfield AK, Miser A, Sloan JA, Wender DB, Rowland KM, Molina R, Cascino TL, Vukov AM, Dhaliwal HS, Ghosh C. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol. 1997 Aug; 15(8):2974-80.
    View PubMed
  414. Okuno SH, Foote RL, Loprinzi CL, Gulavita S, Sloan JA, Earle J, Novotny PJ, Burk M, Frank AR. A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer. 1997 Jun 1; 79(11):2193-9.
    View PubMed
  415. Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O'Neil J, Bilodeau B, Watson P, Mueller B. Information needs and decisional preferences in women with breast cancer. JAMA. 1997 May 14; 277(18):1485-92.
    View PubMed
  416. Loprinzi CL, Abu-Ghazaleh S, Sloan JA, vanHaelst-Pisani C, Hammer AM, Rowland KM Jr, Law M, Windschitl HE, Kaur JS, Ellison N. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol. 1997 Mar; 15(3):969-73.
    View PubMed
  417. Loprinzi CL, Ghosh C, Camoriano J, Sloan J, Steen PD, Michalak JC, Schaefer PL, Novotny PJ, Gerstner JB, White DF, Hatfield AK, Quella SK. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol. 1997 Mar; 15(3):1235-8.
    View PubMed
  418. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol. 1997 Mar; 15(3):1239-43.
    View PubMed
  419. Chalmers KI, Bramadat IJ, Sloan J. Development and testing of the Primary Health Care Questionnaire (PHCQ): results with students and faculty in diploma and degree nursing programs. Can J Nurs Res. 1997 Spring; 29(1):79-96.
    View PubMed
  420. Degner L, Sloan JA, Venkatesh P. The control preferences scale. Canadian Journal of Nursing Research. 1997; 29:21-43.
    View PubMed
  421. Sloan J, Novotny P, Loprinzi C, Nair S Graphical and analytical tools for the analysis of two-period crossover clinical trials SAS Users Group International (SUGI) Conference Proceedings. 1997; 22:1312-1317.
    View PubMed
  422. Sloan J, O'Fallon J, Sargent D. Incorporating Quality of Life Measurement in Oncology Clinical Trials Biometrics Section of the American Statistical Association. 1997:282-287.
    View PubMed
  423. Sloan J, Stewart D. Shelter affordability and housing needs of Canadian food bank users. Canadian Mortgage and Housing Corporation. 1997.
  424. Kristjanson LJ, Sloan JA, Dudgeon D, Adaskin E. Family members' perceptions of palliative cancer care: predictors of family functioning and family members' health. J Palliat Care. 1996 Winter; 12(4):10-20.
    View PubMed
  425. Beaver K, Luker KA, Owens RG, Leinster SJ, Degner LF, Sloan JA. Treatment decision making in women newly diagnosed with breast cancer. Cancer Nurs. 1996 Feb; 19(1):8-19.
    View PubMed
  426. Sloan JA, Yeung AS. Alternative reformulations of Cronbach's Alpha. Proceedings of the Biometrics Section. 1996:367-371.
  427. Degner LF, Sloan JA. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage. 1995 Aug; 10(6):423-31.
    View PubMed
  428. Luker KA, Beaver K, Leinster SJ, Owens RG, Degner LF, Sloan JA. The information needs of women newly diagnosed with breast cancer. J Adv Nurs. 1995 Jul; 22(1):134-41.
    View PubMed
  429. Sloan J, Schwarz C, Neden L. A new graphic representation for trivariate data: tree pictures. Can J Stat. 1995; 23:325-329.
  430. Trylinski C, Sloan J, Nemecek A. Cancer patient trajectory through the Manitoba Health Care system. J Registry Manage. 1995; 21:31-34.
  431. Sloan JA, Schwarz C, Neden L. Dataset on silver-maple-tree growth regulators. Journal of the Statistical Society of Canada. 1995; 23(3):325-9.
  432. Kraut A, Sloan J, Silviu-Dan F, Peng Z, Gagnon D, Warrington R. Occupational allergy after exposure to caddis flies at a hydroelectric power plant. Occupational & Environmental Medicine. 1994 Jun; 51(6):408-13.
    View PubMed
  433. Paterson B, Sloan J. Knowing my body: the lived experience and decision making process of patients with long term type I diabetes. Diabetes Care. 1994; 18:10-19.
  434. Sloan J. Lay-persons guide to professional titles in statistics. Chance. 1994; 7:33.
  435. Sloan J. Statistical consulting is scholarship, too. J Am Stat Assoc. 1994; 48:62-63.
  436. Paterson BL, Sloan JA. A phenomenological study of decision-making experience of individuals with long-standing diabetes. Journal of Diabetes Care. 1994; 18(4):10-9.
  437. Sloan J. The state of nursing research: an outsider's perspective. Nurscene. 1993; 18:9-10.
  438. Sloan J. Considering the research subject's point of view: diary of a lab rat. Nurscene. 1993; 19:16-17.
  439. Degner LF, Sloan JA. Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol. 1992 Sep; 45(9):941-50.
    View PubMed
  440. Heaman M, Beaton J, Gupton A, Sloan J. A comparison of childbirth expectations in high-risk and low-risk pregnant women. Clin Nurs Res. 1992 Aug; 1(3):252-65.
    View PubMed
  441. Sloan J. What do nurses need to know about statistics? Nurscene. 1992; 17:4-5.
  442. Adaskin E, Powell C, Beaton J, Sloan J. A survey of Manitoba baccalaureate nurses' preferences for further study. Nurscene. 1992; 17:10-11.
  443. Gregory D, Russell C, Hurd J, Tyance J, Sloan J. Canada's Indian Health Transfer Policy: the Gull Bay Band experience. Hum Organ. 1992; 51:214-222.
  444. Schwarz C, Sloan J, Neden L. Analysis of a multiple sclerosis dataset. Can J Stat. 1992; 20:91-108.
  445. Sloan J. How to consult with a statistician. The Statistical Consultant. 1992; 9:2-3.
  446. Sloan JA, Western Consortium for Cancer Nursing Research. Development of a staging system for chemotherapy induced stomatitis. Cancer Nursing. 1992; 14:6-12.
  447. Gupton A, Beaton J, Sloan J, Bramadat I. The development of a scale to measure childbirth expectations. Can J Nurs Res. 1991 Summer; 23(2):35-47.
    View PubMed
  448. Kristjanson L, Sloan J. Evaluation of the grief experience for surviving family members. J Palliat Care. 1991; 7:51-56.
    View PubMed
  449. Sloan JA, Sinha SK. Bayesian prediction intervals for a mixture of exponential failure-time distributions for complete and censored samples. Statistics and Probability Letters. 1991; 11:537-545.
  450. Scruby LS, Sloan JA. Evaluation of bereavement intervention. Can J Public Health. 1989 Nov-Dec; 80(6):394-8.
    View PubMed
  451. Sinha SK, Sloan JA. Prediction intervals for a mixture of Weibull failure-time distributions--a Bayesian approach. South African Journal of Statistics. 1989; 23:119-130.
  452. Sinha SK, Sloan JA. Bayes estimation of the parameters and reliability function of the three-parameter Weibull distribution. IEEE Trans on Reliab. 1988; 37:364-369.
  453. Sloan J. Uniform scaling in presenting three-dimensional data via SAS/graph. SAS Communications. 1988; 6:118-120.